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EXECUTIVE SUMMARY 
Background 
The State of Palestine consists of the non-contiguous West Bank including East Jerusalem and the 
Gaza Strip with a densely-packed population. Its unique socioeconomic context is characterized by 
political and economic tensions and has created conditions that facilitate the spread of illicit and 
prescription drug abuse. UNODC Programme Office in the State of Palestine (POPSE) has provided 
technical support to the State of Palestine since 2005, in developing a comprehensive, integrated and 
safe response to the problem of drug dependence and for the continued prevention and care of HIV. 
Since 2014, under the Korea International Cooperation Agency (KOICA) fund, POPSE supported 
the Palestinian Ministry of Health (MoH) under the Project PSEY13; “Supporting the establishment-based 
drug dependence treatment and rehabilitation system for the Palestine National Rehabilitation Centre 
(PNRC)”. PSEY13 was implemented by POPSE, with oversight provided by UNODC Regional 
Office for Middle East and North Africa (ROMENA), and Prevention, Treatment and Rehabilitation 
Section, Division for Operations, UNODC Headquarters (HQ). This assistance consisted of 
supporting the main objective of PSEY13, i.e. a comprehensive system of drug dependence 
treatment carefully established and integrated into the health system in Palestine, with strengthened 
institutional and human resource capacity to provide evidence-based harm reduction and drug 
dependence treatment services at the PNRC. PSEY13 was in line with UNODC’s Thematic Sub 
Programme 5 on Health and Livelihoods (Drugs and HIV) and was formally launched in January 
2014. It was extended in 2018 to February 2019 when it will come to an end. PSEY13 had a budget 
of USD 622,913.00 (expenditure to December 2018; USD611,913: 98%). 
 
Purpose, scope and methodology of the evaluation 
The purpose and scope of the final Independent Project Evaluation of PSEY13 was to assess its 
relevance, effectiveness, efficiency, impact, sustainability, human rights and gender mainstreaming, 
and partnerships and cooperation. It was also to identify areas of improvement and derive 
recommendations and lessons learned from measuring its achievements, as well as needs of further 
assistance for potential future projects with the Palestinian Government, as well as for organizational 
learning and decision-making purposes. The main users of the evaluation results are POPSE, 
ROMENA, KOICA, the Palestinian MoH and the PNRC. The eleven Core Learning Partners 
(CLPs) were identified by POPSE as particularly relevant in the evaluation process, in e.g. reviewing 
and commenting on the TOR and the evaluation questions, as well as the draft evaluation report. The 
remaining stakeholders and informants were invited for interviews, including the CLPs. A 
participatory, age, gender sensitive and gender inclusive as well as a mixed method approach 
comprising a desk review of project documents, interviews, focus groups and observation was used. 
Secondary data sources were cross checked and triangulated through the collected primary research 
data. Desk review of relevant documents, interviews (13 males, 8 females) and focus groups (3 males, 
6 females) and site observation at the PNRC were conducted during the mission in September 2018. 
The evaluation covered the entire timeframe of the project (January 2014 to September 2018, end of 
evaluation mission), focussing on Jerusalem, Ramallah and Bethlehem. The evaluation was conducted 
by one external, independent female evaluator, qualified to doctoral level with two decades of public 
health and clinical experience in drug prevention, treatment and rehabilitation, and of UNODC 
evaluation.  
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Main findings 
Design 
PSEY 13 was designed by POPSE based on the request of the Palestinian MoH and POPSE 
previous experience in the West Bank, to address the institutional and human resource capacity needs 
and governance aspects of an assistance package to contribute to the development of a 
comprehensive system of drug dependence treatment and care, fully integrated into the Palestinian 
health system.  The analysis shows that it was accurately designed to some extent to respond to these 
identified needs. It was realistically designed to achieve construction and staffing of a facility (PNRC) 
fully integrated into the Palestinian health system. The design based on a bi-lateral agreement 
between MoH and KOICA however only achieved the minimum technical specifications and 
standards for operationalisation and did not fully consult with or involve the staff, experienced 
general practitioners, NGOs or Middle Eastern clinicians. It is therefore recommended for the future 
to incorporate projected annual budgets for staffing, maintenance and equipment, and to fully 
involve these stakeholders in facility design, operations and safety standards. The design of 
professional training for PNRC staff was further only at the foundation level, delivered to all clinical 
professions only in English as a collective, and did not fully incorporate Middle Eastern cultural, 
ethical and gender aspects, or existing expertise from NGOs, experienced general practitioners or 
Middle Eastern experts. For the future it is therefore recommended to design training that is specific 
to each clinical discipline, that includes Middle Eastern aspects, and is provided by Middle Eastern 
clinical and NGO experts.  
Relevance 
Prior to implementation of PSEY13, the Palestinian Authority lacked a comprehensive system of 
drug dependence treatment and care fully integrated into the health system. There was limited 
knowledge of professionals, lack of applicable research-based evidence around drug prevalence and 
size of the problem and limited financial and human resources. There was an identified need to 
strengthen the available services in terms of staff, NGO and governmental capacities for evidence-
based drug dependence treatment and rehabilitation. PSEY13 was relevant and suitable in terms of in 
setting up the PNRC to respond to these needs. Technical assistance provided by PSEY13 whilst 
suitable to the priorities and policies of the health sector actors was less relevant to and inclusive of 
civil society. There was limited involvement of very relevant NGOs and experienced general 
practitioners in the support, training and mentoring of PNRC staff, and in the setting up of 
community referral networks to support both patient intake and rehabilitation after treatment. It is 
recommended to utilise experienced general practitioners and NGOs better in future projects, 
especially, those who have extensive and relevant experience providing support to individuals and 
families affected by drug abuse. The relevance of operations standards, OST guidelines; the PNRC 
mission statement, strategic management and governance plan, core policies and care planning were 
developed in line with UNODC and WHO standards, but were the minimum for facility 
operationalisation at start up. Operational standards and systems require more development. 
Efficiency 
The evaluation revealed that PSEY13 utilized its resources efficiently to some extent to achieve its 
objectives and outputs in relation to the inputs and outcomes. It had a strong governance structure. 
Project revisions were incurred in 2016, 2017 and 2018 due to a change in designated location of the 
PNRC originally planned for Ramallah to Bethlehem. Delays in sign off from the MoH, and delays in 
starting the construction of the building in Bethlehem led to corresponding delays in the PSEY13 
work plan, delayed recruitment of PNRC staff, and rescheduling of staff professional training 
activities. Outputs of PSEY13 in terms of technical specifications, costings, facility systems, standards 
and operating protocols for the PNRC were adequate for start-up of the facility, however for the 
future it is recommended to ensure ring fenced resources for ongoing staff and technical capacity, 
and maintenance support required by the Palestinian MoH. There is further a need for scale up over 
time and a requirement for development of strong community rehabilitation support programming in 
providing aftercare within a decentralised model across the West Bank.   
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Partnerships and cooperation 
The evaluation showed that POPSE partnerships in Palestine were efficient, effective and integral to 
implementation of PSEY13. There was strong multi-disciplinary commitment and collaboration of 
key stakeholders across Ministries, National Institute of Public Health, the National Programme on 
Drug Control, Criminal Justice and Crime Prevention in supporting the project; partnerships with the 
Methadone Centre, KOICA, National AIDS Committee and National High Committee for the 
Prevention of Drugs and Psychotropic Substances, but to a lesser extent involvement of the NGOs; 
Caritas, Al Maqdese and Al Sadiq al Tayyeb. All partners were identified from the beginning of the 
project. Interviews revealed that the NGOs Caritas, Al Maqdese and Al Sadiq al Tayyeb whilst having 
strong and positive relations with POPSE, were underutilised in PSEY13, and are an untapped 
resource for future operations of the PNRC (and future similar projects), particularly given the need 
to decentralise drug treatment to primary care, and support patient rehabilitation in communities 
across the West Bank. It is therefore recommended to partner with and fully involve such key in the 
design and operation of future similar projects or follow on projects focusing on aftercare in the 
community. Collaborations with WHO, UNDP, UNICEF, UN Women, and UNRWA were further 
less developed in PSEY13. It is therefore recommended to further develop and include these 
international organisations in similar future projects to ensure their input based on relevant expertise 
and experience in factors relating to drug abuse (gender violence, public health, and vulnerabilities). 
Effectiveness 
Triangulation of data showed that PSEY13 achieved its planned results, with the PNRC representing 
a starting point for the Palestine government in the establishment of a comprehensive system of drug 
dependence treatment and care integrated into their health system. PSEY13 navigated several 
challenges during implementation which centred on delays caused by the continued political crisis 
affecting endorsement of the Drug Law; community resistance toward the initial planned location of 
the PNRC in Ramallah, leading to the subsequent change of site to Bethlehem. Difficulties in 
securing relevant clinical staff occurred which were overcame by working closely with the Palestinian 
National Authority (PNA) but leading to delays in the scheduling of professional training for staff 
recruited to work at the PNRC. It was however only effective to some extent in achieving staff 
capacity building, the 2017 situation assessments., and PNRC technical and operational specifications, 
systems and standards. Interviews showed that there is stakeholder concern around PNRC 
operational standards at start up with regard to sufficient staffing levels for safety; the competency of 
recruited staff in dealing with drug dependence and related co-morbid complexities; the lack of staff 
input into the facility layout, risk assessments and operational planning, and the foundation 
professional training on drug dependence treatment provided by international expert trainers from 
outside Arab cultures. It is recommended for future projects to include clinical staff input into 
operational and safety layout and standards, systems, risk assessments and technical specifications. 
There was also concern around the lack of involvement of key Middle Eastern clinicians, general 
practitioners and NGOs in staff training and support, and in establishing patient referral and 
community rehabilitation pathways. Future projects are advised to include these key stakeholders 
with relevant expertise, community trust and knowledge in capacity building, and in programming   
Impact 
The evaluation revealed that PSEY13 provides a strong starting point for the Palestinian government 
to respond to rising drug use and related risk behaviours in the State of Palestine, by virtue of setting 
up the first drug treatment and rehabilitation centre of its kind that is science, gender and human 
rights-based and fully integrated into the Palestinian health system. PSEY13 is strongly aligned to the 
UN SDG 3 by virtue of its focus on ensuring healthy lives and promote well-being for all and at all 
ages; the UNODC Thematic Programme on Health and Livelihoods (Drugs and HIV); the UNODC 
global programme GLOK32; and regional and country UNODC programmes and projects such as 
PALI06; XNAJ58, XAMW59 and PSEX02. PSEY13 also contributes strongly to key UN priorities 
for Palestine, and existing Palestinian Government strategies on health, drug control, justice reform, 
gender and juvenile justice. Given the PNRC became operational from January 2019, it was however 
not possible to assess its true impact in terms of its response to drug treatment demand, staff 
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capacity building, and associated health and crime related outcomes within the time frame of this 
evaluation.  
Sustainability  
The PNRC became operational by the Palestinian MoH in January 2019. The evaluation shows that 
POPSE technical assistance has through its activities in PSEY13 supported the development of 
Palestinian governmental commitment to support the operation of the PNRC. Potential threats to 
sustainability relate to the requirement for continued governmental funding to support the running of 
the facility (i.e. medicines procurement, staffing and maintenance costs) itself and the need to budget 
for scale up across the West Bank via decentralisation and provision of a follow-up on aftercare 
programme. Ownership is vital to the cascade of clinical training of PNRC staff, and with further 
ongoing professional training, mentoring and peer training identified as key to supporting 
sustainability of PSEY13 outcomes. Future projects are recommended to provide and support 
further technical assistance pertaining to clinical training and staff mentoring by Middle Eastern 
experts and the twinning of the PNRC with a leading UK treatment centre.  
Human Rights, Gender Equality and leaving no one behind 
The evaluation shows that human rights, gender mainstreaming and ‘leaving no one behind’ were only to 
some extent considered in the design and implementation of PSEY13 activities. Some concerns were 
raised by stakeholders during interview around families signing individuals into the PNRC for 
compulsory treatment. It is recommended to include such specific Middle Eastern ethical and human 
rights considerations in future projects. There are also various key populations that require further 
attention in training and programming (e.g. drug dependent women and neonates, children of 
substance using families, prisoners, youth, disabled, patients with co-morbidities and co-infections). 
Main conclusions 
Prior to the implementation of PSEY13 by POPSE, Palestine lacked a comprehensive system of drug 
dependence treatment and care fully integrated into the health system and provided by trained staff. 
POPSE partnerships and co-operations were only effective to some extent. PSEY13 however 
responded strongly to the need to set up the PNRC, develop start up facility technical specifications, 
systems and standards, and increase clinical staff capacity in providing evidence and human rights- 
based drug treatment. Areas of concern centre on the generic foundation training on drug 
dependence treatment delivered to PNRC staff by international experts from outside of the region. 
Staff, NGOs and general practitioners were also not fully consulted in the design of the PNRC itself 
or the training to staff. There were concerns around the PNRC facility in terms of capacity to operate 
safely and in a sustainable manner by the MoH. Future projects are advised to fully involve NGOs 
and primary care services in supporting patient referral and patient community rehabilitation, with 
scale up and decentralisation across the West Bank recommended.  
Main recommendations  
Of the seven recommendations only two are listed below (all recommendations are included in the 
matrix and in the main body of the report).   
Technical Assistance: Improve the design, technical specifications, standards and clinical systems 
of future similar projects such as a follow up community referral and rehabilitation aftercare project, 
by consulting with and involving Middle Eastern clinical experts, PNRC staff, experienced general 
practitioners, and NGOs (Project management, POPSE) 
Training Activities: Improve the design and clinical and cultural applicability of professional 
training in future projects by delivering training that is specific to each clinical discipline, that includes 
Middle Eastern gender, ethical and human rights considerations, and that is provided by Middle 
Eastern clinical and NGO experts (Project management, POPSE) 
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Lessons learned and best practices  
Lessons learnt throughout implementation of PSEY13 centred on the importance of fully involving 
all stakeholders through projects inception, design and implementation. Best Practices centre on the 
defining of facility technical specifications for start-up. These can be applicable to other drug 
treatment facility projects in the region. (all lessons learned and best practices are included in the 
main body of the report) 
 
 
 
 xiii 
SUMMARY MATRIX OF FINDINGS, EVIDENCE 
AND RECOMMENDATIONS  
Findings Evidence (sources that 
substantiate findings) 
Recommendations 
There was a lack of PNRC 
staff, general practitioner and 
NGO consultation in the 
design, technical specifications, 
standards and systems in 
supporting operationalisation 
of the PNRC as a facility, 
which requires the operational 
support of decentralisation and 
scale up of community referral 
and rehabilitation using 
primary services and NGOs 
across the West Bank. 
Interviews, focus groups and 
observation 
Recommendation 1 – (Technical 
Assistance) Improve the design, 
technical specifications, 
standards and clinical systems of 
future similar projects such as a 
follow up community referral 
and rehabilitation aftercare 
project, by consulting with and 
involving Middle Eastern clinical 
experts, PNRC staff, 
experienced general 
practitioners, and NGOs 
(Project management, UNODC 
Programme Office in the State 
of Palestine) 
The design of professional 
training for PNRC staff on 
addiction treatment was only at 
the foundation level, delivered 
to all clinical professions solely 
in English as a collective 
training, but did not fully 
regard Middle Eastern gender, 
cultural and ethical aspects of 
drug abuse and drug treatment, 
or utilise existing expertise 
from community NGOs, 
experienced general 
practitioners or Middle Eastern 
clinical experts. 
Interviews, focus groups and 
observation 
Recommendation 2 - (Training 
Activities): Improve the design 
and clinical and cultural 
applicability of professional 
training in future projects by 
delivering training that is specific 
to each clinical discipline, that 
includes Middle Eastern gender, 
ethical and human rights 
considerations, and that is 
provided by Middle Eastern 
clinical and NGO experts 
(Project management, UNODC 
Programme Office in the State 
of Palestine) 
The PNRC became operational 
by the Palestinian MoH in 
January 2019. Potential threats 
to sustainability relate to the 
requirement for continued 
governmental funding to 
support staff capacity building, 
commitment and the running 
of the facility (including 
maintenance, equipment and 
staff). 
Interviews, focus groups and 
observation 
Recommendation 3 - 
(Sustainability): Ensure that 
future similar projects have 
sufficient financial resources to 
support sustainable operations, 
via e.g. 12-month work planning 
and ring-fenced resources for 
maintenance, patient demand 
and staff support. (Project 
management, UNODC 
Programme Office in the State 
of Palestine) 
 
 xiv 
POPSE partnerships in 
Palestine were efficient, 
effective and integral to 
implementation of PSEY13. 
There was strong multi-
disciplinary commitment and 
collaboration of relevant key 
stakeholders. The NGOs 
Caritas, Al Maqdese and Al 
Sadiq al Tayyeb whilst having 
strong and positive relations 
with POPSE, were however 
underutilised and are an 
untapped resource for future 
similar projects, particularly 
given the need to decentralise 
drug treatment to primary care, 
and support patient 
rehabilitation in the 
community. Collaborations 
with WHO, UNDP, UNICEF, 
UN Women, and UNRWA 
were less developed in 
PSEY13. 
Desk review, interviews and 
focus groups 
Recommendation 4-
(Partnerships and Cooperation)-: 
Engage with all relevant 
stakeholders (country partners, 
Ministerial, health professionals 
and NGOs) and further develop 
existing collaborations with 
WHO, UNDP, UNICEF, UN 
Women, and UNRWA in future 
similar projects. (Project 
management, UNODC 
Programme Office in the State 
of Palestine and UNODC 
Regional Office for Middle East 
and North Africa) 
Human rights considerations 
were only to some extent 
included in the design and 
implementation of PSEY13. 
Desk review, interviews, focus 
groups and observation 
Recommendation 5 - (Human 
Rights): Ensure human rights are 
considered and respected in the 
provision of voluntary drug 
treatment access and provision 
in future similar projects. 
(Project management, UNODC 
Programme Office in the State 
of Palestine) 
Gender mainstreaming was 
only to some extent adequately 
included in PSEY13, which 
achieved the female gender 
quote of staff training, and 
considered the unique drug use 
and dependence characteristics 
of women in the design of 
PNRC facility. Further training 
is also required on drug 
dependence during pregnancy 
and after delivery, and girls 
affected by sexual violence 
Needs of other key vulnerable 
groups were however not fully 
considered.. Several key 
populations were further 
identified as requiring 
additional training and 
programming specificity by the 
PNRC. 
Desk review, interviews, focus 
groups and observation 
Recommendation 6 - (Gender 
Mainstreaming and Leaving No 
one Behind): Recognise and 
respond to the needs of 
identified key vulnerable 
populations in future similar 
projects (Project management, 
UNODC Programme Office in 
the State of Palestine) 
  
 
 
 
xv 
PSEY13 was operated by a 
small team of three staff at 
POPSE and had a strong 
governance structure with 
support from ROMENA and 
HQ. PSEY13 however was 
dependent on the efforts of 
this small team of staff, and in 
particular, dependent on the 
very strong and positive 
relationships the project 
coordinator had developed 
with all stakeholders involved 
in PSEY13. 
Desk review, interviews and 
focus groups 
Recommendation 7 - (Staffing): 
Ensure sufficient project staffing 
capacity to support all aspects of 
pre-assessment, design, planning 
and implementation of future 
similar projects. (Project 
management, UNODC 
Programme Office in the State 
of Palestine and UNODC 
Regional Office for Middle East 
and North Africa) 
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I. INTRODUCTION 
Background and context 
 
Map of the State of Palestine (source: UN Geospatial information website: 
http://www.un.org/Depts/Cartographic/english/htmain.html ) 
The State of Palestine consists of the non-contiguous West Bank including East Jerusalem and the 
Gaza Strip with a densely packed population. Its unique socioeconomic context is characterized by 
political and economic tensions, and has created conditions that facilitate the spread of illicit drug use 
among Palestinians, particularly among youth, women and family members of current drug users.12. 
The use, trafficking and selling of drugs is a growing problem, creating an array of social, 
psychological, health, economic and political problems for Palestinians. Drugs include marijuana, 
prescription medications (anti-depressants, Z-hypnotics, benzodiazepines and analgesics), and novel 
psychoactive substances (NPS) (‘sintetique marijuana’), with reported high dose use of methadone, 
morphine, phencyclidine, barbiturates, benzodiazepines, synthetic opioids such as Tramadol, and 
GABA drugs such as pregabalin. There are an estimated 26,500 high-risk drug users (HDU) in 
________ 
1 (UNODC/KOICA/WHO (2017). Illicit Drug Use in Palestine: A Qualitative Investigation Formative phase study report. Palestinian 
National Institute of Public Health, Ministry of Health, UNODC/KOICA/WHO occupied Palestinian Territory, 
November 2017.  
2 (UNODC/KOICA/WHO (2017). Estimating the Extent of Illicit Drug Use in Palestine Palestinian National Institute of Public 
Health, Ministry of Health, UNODC/KOICA/WHO occupied Palestinian Territory, November 2017. 
INDEPENDENT EVALUATION OF: PSEY13 
 
2 
P
U
B
L
IC
A
T
IO
N
 T
IT
L
E
 H
E
R
E
 
 
Palestine, consisting of 1.8% of the male population aged over 15 years. Prevalence of Hepatitis C 
(and human immunodeficiency virus, HIV to a lesser extent) has increased and is associated with 
sharing of needles and other equipment between HDU3 who inject heroin and cocaine.  
In the Palestinian National Policy Agency (PNPA), which forms part of the Palestinian Reform and 
Development Plan 2008-2010 (PRDP), the Palestinian National Authority (PA) state that quality of 
life is one of four national policy goals towards which their actions must lead. The PRDP determines 
that a strengthened social coherence and solidarity, matched with improved quality of health services, 
is a high-level objective for the PRDP period so that the most vulnerable areas and groups in society 
are supported and the culture, national identity and heritage of the Palestinian people are reinforced. 
The PRDP states that “increased capacity of public sector organization involved in social policy making, provision of 
well-targeted social assistance, and the delivery of basic education and health services will have a direct positive effect on 
the daily lives of citizens.”4 This is also part of the Strategic Objectives for the Health Sector indicating 
that the Palestinian Ministry of Health (MoH) should make efforts towards “achievement of the best 
possible outcomes from health care services.” 5The Palestinian MoH heads two major multi-sectorial bodies 
directly involved in the national response to drug use, dependence and its related negative health and 
social consequences. The national bodies include the Palestinian National High Committee for the 
Prevention of Drugs and Psychotropic Substances and the National AIDS Committee. The National 
High Committee for the Prevention of Drugs and Psychotropic Substances recognizes drug 
dependence as a multi-factorial health disorder and has been actively engaged in the development and 
coordination of the national response. 
The UNODC Programme Office in the State of Palestine (POPSE) has been providing technical 
assistance to the State of Palestine since 2005, especially with regard to the development of a 
comprehensive, integrated and safe response to the problem of drug dependence and for the 
continued maintenance of a low HIV epidemic, prevention and care. It started with the development 
and implementation of HIV prevention and care strategies among drug users in the West bank and 
Gaza through established drop-in centres. HIV prevention and care services used to be quite limited 
in Palestine, but after the implementation of the Global Fund grant (2009-2014) voluntary 
counselling and testing services are now available in the West Bank, in addition to access to anti-
retroviral treatment for people living with HIV. With the technical assistance of POPSE, community 
outreach services are being provided to people who use drugs and a drop-in centre was established in 
the West Bank and in Gaza providing condoms, needles and syringes to people who inject drugs. 
Prior to the project “Supporting the Establishment-based Drug Dependence Treatment and Rehabilitation System 
for the Palestine National Rehabilitation Centre” (PSEY13), drug dependence treatment (limited to 
detoxification) was provided by a limited number of centres operated by non-governmental 
organizations (NGOs) (Al Huda, Al Sadeq al Tayeb) geographically scattered across the West Bank. 
Psychosocial rehabilitation is offered by these NGOs and limited outpatient clinics are operated by 
the Palestinian MoH. Evidence-based drug dependence treatment and the availability of more 
comprehensive services were scarce. Pharmacotherapy was absent (antagonist pharmacotherapy or 
agonist therapy for people dependent on opiates). Anecdotal data suggested that an increasing 
________ 
3 Defined as ‘recurrent drug use that causes actual harm (negative consequences) to the person (including dependence, but also other health, 
psychological or social problems) or places the person at a high probability/risk of such harm’. 
4 Palestinian Reform and Development Plan 2008-2010 (PRDP). Available at online: 
http://siteresources.worldbank.org/INTWESTBANKGAZA/Resources/PRDP08-10.pdf  
5 Final Terms of Reference. Final Independent Project Evaluation. “Supporting the establishment of evidence-based drug dependence 
treatment and rehabilitation system for the Palestine National Rehabilitation Centre”  UNODC POPSE: Jerusalem.  
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number of Palestinians residing in the West Bank sought drug dependence treatment in Jordan, if 
they had the necessary financial resources.  
Beside the unsystematic provision of drug dependence treatment and rehabilitation services, the 
Palestinian Authority lacked a comprehensive system of drug dependence treatment and care fully 
integrated into the health system. This was further hampered by the limited knowledge of 
professionals, lack of research-based evidence that is applicable, and limited financial and human 
resources. Before PSEY13, there was a considerable need to strengthen the available services in 
terms of NGO and governmental capacities for evidence-based drug dependence treatment and 
rehabilitation.  
The Palestinian MoH identified the lack of technical and human resource capacity on evidence-based 
assessment, diagnosis and treatment of drug dependence as a major weakness in its health system and 
officially requested support from UNODC POPSE to build its capacity in this regard. In view of a 
perceived increase in the number of drug users and the high demand for drug dependence treatment, 
the MoH requested support to set up a governmental treatment and rehabilitation centre in the West 
Bank. In 2012, the Korea International Cooperation Agency (KOICA) answered this request and 
signed an agreement with the MoH for the establishment of the first Palestine National 
Rehabilitation Centre (PNRC) for a total amount of $5,000,000.  
POPSE was requested by the MoH to provide technical assistance to build its capacity to offer a 
proper structure for drug users. Technical assistance was provided by POPSE, with oversight by 
UNODC Regional Office for Middle East and North Africa (ROMENA), and UNODC HQ in 
Vienna. This assistance was to provide technical support, especially with regard to the development 
of a comprehensive, integrated and safe response to the problem of drug dependence in Palestine, 
and a system of drug dependence treatment and care, fully integrated into the health system with 
strengthened institutional and human resource capacity. All activities were responding to this request 
for support through developing treatment and facility protocols, policies and procedures, and 
guidelines; building the capacity of the PNRC staff to operate this facility and receive cases; and 
conducting a drug size estimation assessment. POPSE assistance to the MoH follows the Action Plan 
for the Implementation of the Declaration on the Guiding Principles of Drug Demand Reduction:  
1) Facilitating information sharing on best practices/strategies;  
2) Providing guidance and assistance for the development of drug demand reduction strategies and 
programmes in line with the guiding principle of drug demand reduction, and;  
3) Providing assistance for the establishment of national information system, including data on 
regionally and internationally recognized core indicators. 
PSEY13 had one main objective; a comprehensive system of drug dependence treatment carefully 
established and integrated into the health system in Palestine, with strengthened institutional and 
human resource capacity to provide evidence-based harm reduction and drug dependence treatment 
services at the PNRC. Trainings and awareness raising were provided on evidence-based drug 
dependence treatment as a multifactorial chronic disease, with a focus on the relationship between 
the drug conventions and human rights. Efforts had previously been undertaken to ensure that the 
right to health was included in the draft of the Palestinian Drug Law. Hence, the PNRC will not 
provide long term residential treatment programmes (over 120 days), nor community sentences such 
as structured treatment programmes organized as part of a community sentence and other probation 
orders using a linked treatment condition.  
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PSEY13 was in line with UNODC’s Thematic Sub Programme 5 on Health and Livelihoods (Drugs 
and HIV) and was formally launched in January 2014. It was extended in 2017 to December 2018 
and extended again in 2018 to February 2019 when it is coming to an end. Due to delays in 
construction timelines and re-scheduling of staff trainings as a consequence, the PNRC as a facility 
became operational in January 2019. 
Purpose and scope of the evaluation 
This final Independent Project Evaluation of PSEY13 is the first and only evaluation of the project 
and covered the entire timeframe of the project from January 2014 to September 2018 (end of field 
mission of the evaluation). The geographical coverage of the evaluation was the Occupied Palestinian 
Territories, West Bank (Jerusalem, Ramallah and Bethlehem). The purpose of the final evaluation was 
three-fold: 
(1) Assess the implementation of the project activities, and the results obtained to enable 
UNODC to provide the donor and national counterparts with an assessment of the extent to 
which the objective, outputs and outcomes were met.  
(2) Ensure accountability to the donor (KOICA), the national stakeholders (Palestinian National 
Institute of Public Health), and the National counterpart (MoH). Provide an assessment of 
whether the resources were wisely utilized. 
(3) Support UNODC to identify areas of improvement not only in terms of project 
management but also in terms of continuation of technical assistance to the national 
counterpart. Identify best practices, lessons learnt and needs of further assistance for 
potential future project with the Palestinian Government, as well as for organizational 
learning and decision-making purposes.  
 
The scope of the final evaluation of PSEY13 was to assess the following DAC criteria; its relevance, 
effectiveness, efficiency, impact, sustainability, human rights and gender mainstreaming, and 
partnerships and cooperation; to identify areas of improvement and derive recommendations and 
lessons learned from measuring achievements, as well as needs of further assistance for potential 
future projects with the Palestinian Government, as well as for organizational learning and decision-
making purposes The main users of the evaluation are POPSE, ROMENA, KOICA, the Palestinian 
MoH and the PNRC. 
The composition of the evaluation team 
The evaluation was conducted by one external, independent female evaluator, qualified to doctoral 
level with two decades of public health and clinical experience in drug prevention, treatment and 
rehabilitation, blood borne viruses, and health responses for vulnerable groups. The evaluator further 
had previous experience of UNODC Independent Project Evaluations as Lead Evaluator in the 
thematic areas of the regional programme of HIV Prevention, Treatment, Care and Support in 
Prison Settings in Sub Saharan Africa6, and regional Response to the Social and Livelihood Needs for 
HIV/AIDS Prevention in East Africa.7.  
________ 
6 UNODC (2017) Independent Evaluation of Project XSS V02 HIV Prevention, Treatment, Care and Support in Prison Settings in Sub 
Saharan Africa. Available at 
http://www.unodc.org/documents/evaluation/Independent_Project_Evaluations/2017/XSSV02_independent
_project_evaluation_report_2017.pdf 
7 UNODC (20170.  Independent Evaluation of Project XAFK 45: Response to the Social and Livelihood Needs for HIV/AIDS 
Prevention in East Africa. Available at http://www.unodc.org/unodc/en/evaluation/independent-project-
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Evaluation methodology 
The evaluation methodology conformed to the United Nations Evaluation Group (UNEG) Norms 
and Standards, as well as the UNODC Evaluation Policy, Norms and Standards. It was underpinned 
by a participatory, age, gender sensitive and gender inclusive as well as mixed method approach 
which sought the views and assessments of all parties identified as Core Learning Partners (CLP), 
stakeholders and other informants. A gender sensitive and inclusive approach was used to better 
understand drug abuse and drug treatment service provision, by taking into account the societal and 
cultural factors involved in drug use and gender-based exclusion and discrimination across 
Palestinian public and private life. Eleven CLPs were the main stakeholders identified by POPSE 
deemed as particularly relevant to be involved throughout the evaluation process, i.e. in reviewing 
and commenting on the TOR and the evaluation questions, reviewing and commenting on the draft 
evaluation report, as well as facilitating the dissemination and application of the results and other 
follow-up action. Stakeholders and informants included all those invited to participate in the 
interviews and focus groups, including the CLPs. Hence the evaluation involved multiple 
perspectives, views and assessments both within and outside UNODC.  
 
The evaluation utilized a mixture of primary and secondary sources of data to assess relevance, 
effectiveness, efficiency, impact, sustainability, human rights and gender mainstreaming, and 
partnerships and cooperation, and derive recommendations and lessons learned from measuring 
achievements of PSEY13 and contributing to future operation of similar projects.  
 
The evaluation analysed all relevant information in secondary data sources via comprehensive desk 
review of; the PSEY13 project document, PSEY13 project reports 2014-2018 and revisions 2016-
2018; financial reports, training evaluations, thematic programmes, UNODC technical reports and 
guidance, relevant external documents (e.g. United Nations Development Assistance Framework 
(UNDAF); sustainable development goals (SDG); UN and global/regional strategies; etc.), 
national/regional public health reports, the situational assessment reports89.; training cohort analysis, 
project disbursement data and any other documents that provided further evidence for triangulation 
(Annex III).  
 
Quantitative data utilising the evaluation questions regarding effectiveness, efficiency were collected 
relating to project disbursement and training cohort/evaluation (basic and brief intervention) 
descriptive analysis. The Inception report methodology had included a short online survey with 
staff and trainees not reached by the mission. This was deemed unnecessary given that all staff and 
trainees attended the focus group at the PNRC during the evaluation mission. 
 
Primary data sources collected via qualitative methods were used alongside secondary data to derive 
conclusions and recommendations. Qualitative data collection using interviews with stakeholders 
(CLP, other identified stakeholders) (face-to-face or by telephone), focus group discussions with 
stakeholders and informants, and a site visit to the PNRC with observation (Annex II), utilised all 
evaluation questions, which investigated project relevance, effectiveness, efficiency, impact, 
sustainability, human rights and gender mainstreaming, partnerships and cooperation, and lessons 
learnt. Focus groups were used to obtain detailed information about personal and group feelings, 
                                                                                                                                                              
evaluations-2015.html 
8 (UNODC/KOICA/WHO (2017). Illicit Drug Use in Palestine: A Qualitative Investigation Formative phase study report. Palestinian 
National Institute of Public Health, Ministry of Health, UNODC/KOICA/WHO occupied Palestinian Territory, 
November 2017.  
9 (UNODC/KOICA/WHO (2017). Estimating the Extent of Illicit Drug Use in Palestine Palestinian National Institute of Public 
Health, Ministry of Health, UNODC/KOICA/WHO occupied Palestinian Territory, November 2017. 
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perceptions and opinions around implementation of activities and outcomes of the project PSEY13 
(for example the staff focus group at the PNRC).  
 
The evaluation involved all identified stakeholders (CLPs and general stakeholders) and informants 
of PSEY13. All efforts were made by the evaluator to reach and consult with evaluation participants 
relevant to PSEY13. No additional stakeholders were identified and interviewed apart from those 
already identified by the UNODC POPSE project manager in the terms of reference (ToR) (see 
Annex IV and Figure II for detail). Stakeholders (CLPs and general stakeholders) and informants 
consulted in the evaluations included the Palestinian MoH (Health, International Cooperation, 
Drugs), Ministry of Interior, National Institute for Public Health, National Programme on Drug 
Control Criminal Justice and Crime Prevention, Civil Police, Anti-Narcotic Department; KOICA, 
WHO, NGOs working with UNODC (Al Maqdese, Caritas, Friends of Life, Al Sadiq al Tayyeb), 
United Nations (UNSCO), UNODC Project management and staff at HQ, Cairo and Jerusalem; key 
staff at the Methadone Centre in Ramallah, and relevant operational staff and staff trainees at the 
PNRC (senior management, staff trainees, specialised medical practitioners, psychiatrists, 
occupational therapists, social workers, psychologists, outreach workers) and direct beneficiaries 
(consultants).  
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Figure II. Stakeholders interviewed for the final Independent Project Evaluation of 
PSEY13. 
The field missions were as follows;  
 
• In depth face-to- face interviews with POPSE and the UN Country team in Jerusalem, 25th 
September 2018.  
• Focus group discussion with the donor KOICA in Ramallah, 25th September 2018.  
• In depth face-to-face interviews with the Palestinian Ministry of Health, and National 
Counterpart Methadone Centre in Ramallah, 26th September 2018.   
• In depth face-to-face interviews with WHO / Palestinian National Institute of Public Health 
in Ramallah, 26th September 2018.  
• In depth face-to-face interviews with Palestinian Civil Police, Ministry of Interior, National 
Programme on Drug Control, criminal justice and crime prevention, Anti-Narcotic 
Department in Ramallah, 26th September 2018.  
• In depth face-to-face interviews with NGOs in Jerusalem, 27th September 2018.  
• Site visit to the PNRC with observation in Bethlehem 27th September 2018. 
• Focus group discussions with staff at the PNRC in Bethlehem, 27th September 2018.  
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Triangulation of data 
Analysis of data reviewed and collected during the mission, triangulated across sources and data 
types, methods, theories and descriptive/statistical analysis, and assessed and determined the effects 
of outcomes and impacts (intended or unintended) for different types of duty bearers and right 
holders in disaggregated fashion. Secondary data sources were cross checked and triangulated 
through the collected primary research data.  
 
Limitations to the evaluation 
No limitations were identified in the course of the evaluation mission. There was no change to the 
time allocated for the various steps in the evaluation process, which could have caused a limitation to 
the evaluation. 
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II.  EVALUATION FINDINGS 
 
The Palestinian National Rehabilitation Centre (source: personal mobile phone of the 
evaluator) 
Design 
Evaluation questions:  
➢ Was the design of PSEY13 accurate and realistic in relation to its set objective and outcomes or should 
there be any change for any future similar project? 
➢ Was the PSEY13 designed in line with the national needs? 
➢ How did the 2017 situational assessment findings (trends and prevalence of illicit drug use and non-
medical use of prescription drugs including size estimation study, drug dependence treatment demand 
and service delivery gaps) inform the PNRC? 
 
The evaluation showed that PSEY 13 was realistically designed to respond to the reported national 
need (increase in the number of people who use drugs, increased demand for drug dependence 
treatment, and lack of technical and human resource capacity on evidence-based drug treatment). 
Evidence provided by the 2017 situation assessments and responses1011.provided timely and accurate 
________ 
10 (UNODC/KOICA/WHO (2017). Illicit Drug Use in Palestine: A Qualitative Investigation Formative phase study report. 
Palestinian National Institute of Public Health, Ministry of Health, UNODC/KOICA/WHO occupied Palestinian 
Territory, November 2017.  
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detail regarding drug use trends, prevalence of illicit drug use and non-medical use of prescription 
drugs, a size estimation, drug dependence treatment demand and service delivery gaps.  
 
According to desk review of the PSEY13 project document, PSEY13 project reports 2014-2018 and 
revisions 2016-2018, and supported by qualitative data sources, PSEY 13 was designed by POPSE 
based on the request of the Palestinian MoH and POPSE previous experience in the West Bank, to 
address the institutional and human resource capacity needs and governance aspects of an assistance 
package to contribute to the development of a comprehensive system of drug dependence treatment 
and care, fully integrated into the Palestinian health system. It was accurately designed to some 
extent, in terms of using the situation assessments to inform the design of the PNRC as a facility 
responding to the need for drug treatment in the West Bank.   
 
The design of PSEY13 was multi-faceted. A comprehensive log frame was established with a detailed 
monitoring tool used to measure progress at regular intervals. The targeted design and 
implementation of PSEY13 supported the development of the PNRC service specifications, systems, 
protocols, standard operating procedures (SOP), and cost analysis of staffing and operationalising the 
PNRC. These design aspects strongly support the achievement of an integrated drug treatment 
service (the PNRC) to more accurately respond to the drug dependence treatment need in Palestine. 
A comprehensive log frame was established with a detailed monitoring tool used to measure progress 
at regular intervals. 
Design was developed based on a systematic approach that involved capacity building training and 
advocacy, and empowerment of professionals working on drug dependence treatment and HIV 
prevention and care. In terms of design of training activities, PSEY was less accurate. The situation 
assessments however did not fully input into the design of trainings. Professional training evaluations 
by the staff recruited by the MoH to work at the PNRC reported satisfaction with the training as 
foundation to understanding addiction treatment. Interviews with stakeholders and focus groups 
with PNRC staff however revealed that the design and delivery of this professional training whilst 
useful as basis to understanding addictions, was delivered to the PNRC staff as a collective (i.e. 
pharmacist, psychologist, psychiatrist, nurse). It was also delivered solely in English by international 
experts. Stakeholders and staff however observed concern that the training was not specific to their 
clinical professions, nor was it cognisant of the Middle Eastern cultural, gender and ethical aspects of 
drug abuse, and treatment of addiction within the Palestinian context. It was further viewed by 
training participants as too theoretical given their lack of direct patient experience with drug abuse 
and dependence, and their need for clinical mentoring and practice-based education. 
Recommendations as regards improvements for future professional trainings therefore include; 
• staff preference for on-going in-depth clinical training, practice education and mentoring by 
Middle Eastern drug treatment clinical experts in Arabic; 
• the provision of applied and clinical specific training particular to each profession in order to 
develop skills and expertise in dealing with the complexities of poly drug dependence and 
other scenarios (i.e. management of withdrawal conditions or poly drug dependence, 
management of pregnant women, management of co-morbidities); 
• delivery of training which incorporates particular cultural, gendered and ethical aspects of 
drug abuse and treatment in the Middle East; 
                                                                                                                                                              
11 (UNODC/KOICA/WHO (2017). Estimating the Extent of Illicit Drug Use in Palestine Palestinian National Institute of 
Public Health, Ministry of Health, UNODC/KOICA/WHO occupied Palestinian Territory, November 2017. 
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• mentoring by Middle Eastern clinical experts.  
 
Interviews and focus groups during the mission revealed that the design of PSEY13 based on a bi-
lateral agreement between MoH and KOICA achieved the construction of the PNRC facility and 
technical specifications around the equipping of the facility. There were however some discrepancies 
between MoH and KOICA in terms of agreed final technical specifications pertaining to staffing, 
protocols for waiting lists, SOP, equipment and technical listings, and 12-month work plans for the 
PNRC itself. This means that the PNRC is staffed and equipped at the minimum level for operation.  
It is therefore recommended for the future to develop annual work plans, with projected budgets 
which incorporate sufficient staffing, equipment and facility maintenance needs.  
Interviews and focus groups further reported on the lack of PNRC staff, experienced general 
practitioner and NGO consultation in the design and operation of the PNRC as a facility, and lack of 
input of experienced NGOs and general practitioners into professional training activities for staff.  
Given their expertise these stakeholders should have been fully involved in the design and 
development of professional training, and operational standards, assessment of risk, facility safety 
standards, and systems of the PNRC. A recommendation for future projects is therefore to centre on 
the involvement of facility staff in order to promote ownership, and utilise their expertise and 
experienced NGOs and experienced general practitioners in the design and operation of professional 
training, and facility technical specifications, standards and operationalising systems.   
Summary - Design 
PSEY 13 was realistically designed to respond to the national demand for drug dependence 
treatment, the need for generation of technical and human resource capacity on evidence-based drug 
treatment and achieved the construction and staffing of a drug treatment facility (PNRC) fully 
integrated into the Palestinian health system. It was accurate to some extent. 
The design of professional training for PNRC staff on addiction treatment was however less 
accurate, and only at the foundation level, delivered to all clinical professions only in English as a 
collective, and did not fully incorporate Middle Eastern cultural, ethical and gender aspects, or 
existing expertise from NGOs, experienced general practitioners or Middle Eastern clinical experts.  
For the future it is therefore recommended to design training that is specific to each clinical 
discipline, that includes Middle Eastern gender, ethical and human rights considerations, and that is 
provided by Middle Eastern clinical and NGO experts.  
The design based on a bi-lateral agreement between MoH and KOICA further only achieved the 
minimum technical specifications and standards for operationalisation of the PNRC at start up.  It is 
therefore recommended for the future to incorporate projected annual budgets for staffing, 
maintenance and equipment, and to fully involve staff, NGOs and experienced general practitioners 
in facility design and safety standards. 
Relevance 
Evaluation questions:  
➢ To what extent were the PSEY13 implemented activities and services set up relevant and suitable to 
achieve the expected results? 
➢ To what extent were the PSEY13 implemented activities suited to the priorities and policies of the 
health sector actors and civil society? 
➢ To what extent are the PSEY13 outputs; Standard Operating Procedures for Treatment Protocol, the 
National OST operational guidelines; the development of the PNRC mission statement, strategic 
management and governance plan, core policies and care planning; training relevant to the needs of the 
target group, recipient and donor? 
EVALUATION FINDINGS 
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Prior to implementation of PSEY13, the Palestinian Authority lacked a comprehensive system of 
drug dependence treatment and care fully integrated into the health system. There was limited 
knowledge of professionals, lack of applicable research-based evidence around drug prevalence and 
size of the problem and limited financial and human resources. There was an identified need to 
strengthen the available services in terms of staff, NGO and governmental capacities for evidence-
based drug dependence treatment and rehabilitation.  
 
The evaluation shows that PSEY13 was relevant and suitable in terms of setting up the PNRC to 
provide drug treatment in response to the identified need based on the increase in the number of 
drug users and the high demand for drug dependence treatment in the State of Palestine, as 
evidenced by the 2017 situation assessment1213. 
 
The PSEY13 technical assistance was relevant and suitable in terms of responding to the need to 
capacity build clinical staff in the area of drug treatment provision, and support governance aspects in 
the development of a comprehensive system of drug dependence treatment and care fully integrated 
into the Palestinian health system. Prior to PSEY 13 drug treatment was not integrated into the 
health system, nor were staff trained fully in evidence and human rights-based drug treatment 
provision.  
 
The activities were further very suited to the priorities and policies of the health sector in Palestine 
but were less developed with regarding to including civil society. Interviews and focus groups 
reported lack of engagement in general with civic society, and particularly with low consultation and 
input from very relevant NGOs such as Maqdese, Caritas, Al Sadeq al Tayeb, and experienced 
general practitioners in the support, training and mentoring of PNRC staff, and in the set-up of 
community referral and rehabilitation networks to support patient intake and recovery. It is therefore 
recommended to utilise NGOs and experienced general practitioners better in future projects, 
especially, those who have extensive and relevant experience in providing drug dependence 
treatment, family and community support, and who have community trust in the State of Palestine.  
 
Triangulation of data revealed that the relevance of SOPs, the National OST operational guidelines; 
the development of the PNRC mission statement, strategic management and governance plan, core 
policies and care planning were developed in line with UNODC and WHO standards but were the 
minimum for facility operationalisation at start up.  It is therefore recommended to develop these 
further within the future operation of the PNRC and it’s 12-month planning to ensure optimal 
staffing and technical response to patient demand for drug treatment in the West Bank.  
 
Summary - Relevance 
PSEY13 was relevant and suitable to the State of Palestine on the basis of responding to identified 
need for drug treatment provision and evidence of rising drug use and dependence trends.  
Technical assistance was further relevant and suitable to the priorities and policies of the health 
sector actors but less inclusive of civil society. There was however a lack of engagement with very 
________ 
12 (UNODC/KOICA/WHO (2017). Illicit Drug Use in Palestine: A Qualitative Investigation Formative phase study report. 
Palestinian National Institute of Public Health, Ministry of Health, UNODC/KOICA/WHO occupied Palestinian 
Territory, November 2017.  
13 (UNODC/KOICA/WHO (2017). Estimating the Extent of Illicit Drug Use in Palestine Palestinian National Institute of 
Public Health, Ministry of Health, UNODC/KOICA/WHO occupied Palestinian Territory, November 2017. 
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relevant NGOs and experienced general practitioners in the support, training and mentoring of 
PNRC staff, and in the set-up of community referral and rehabilitation networks.  
It is therefore recommended to further develop operational standards within the PNRC and enhance 
its yearly planning to ensure optimal staffing and technical response to patient demand for treatment 
in the West Bank.  
Efficiency 
Evaluation questions:  
➢ Has UNODC used its resources in an effective manner to achieve the objective and various outcomes 
of PSEY13? 
➢ To what extent was the PSEY13 governance structure adequate? 
➢ To what extent are the PSEY13 outputs; monitoring and evaluation protocol and tools adequate? 
➢ To what extent is the PSEY13 outputs; cost analysis of the equipment and health consumables to be 
purchased with specifications for the PNRC adequate? 
 
Triangulation of data and in particular the desk review of the PSEY13 project document, financial 
reports, PSEY13 project reports 2014-2018 and revisions 2016-2018, show that PSEY13 utilized its 
resources efficiently to some extent to achieve its objectives, outputs in relation to the inputs and 
outcomes. The total approved budget donated by KOICA was USD 622,913, and 94.7% was spent 
at the time of the evaluation (end of field mission in September 2018) (USD 590,496). In addition to 
PSC (13%), general operating and other direct costs (3.5%), 3% was spent on travel, 13.2% on 
training, 27% on assessment, and 35% on consultants and staff, which is a balance of 5.3%.  The 
balance by January 2019 is 0%.  See Figure I for disbursement history. 
Time periods 
throughout the life 
time of the project 
(01/2014 –02/2019)  
Total Approved 
Budget                 
Expenditure   Expenditure in %      
January 2014 – 
June 201814 
USD 622,913  USD 530,364 85.1% 
Time period 
covered by the 
evaluation 
Total Approved 
Budget                 
Expenditure   Expenditure in %      
January 2014 – 
September 2018  
USD 622,913.00 USD 590,496 94.7% 
Time period post 
evaluation 
Total Approved 
Budget                 
Expenditure   Expenditure in %      
October 2018 to 
January 2019 
USD 622,913.00 USD 32,417 100% 
Figure I. Disbursement History (previous page) 
Project revisions were incurred in 2016, 2017 and 2018 due to a change in designated location of the 
PNRC originally planned for Ramallah to Bethlehem. Delays in sign off from the MoH, and delays in 
starting the construction of the building in Bethlehem however led to corresponding delays in the 
project work plan, delayed recruitment of suitable clinical staff, and rescheduling of staff professional 
________ 
14 Terms of Reference June 2018.  
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training activities. This caused low expenditure in 2013 (nil), 2014 (USD32,137) and 2015 
(USD63,426). A request was also made for additional funds for the situational assessment to evaluate 
the extent of drug use and to map services available to drug users in the State of Palestine.  
PSEY13 had a strong governance structure supported by a small efficient team of three staff 
members at POPSE, consisting of a Project Manager (SC SP-5), a General Services Assistant (SC SP-
3), a Reporting and Project Development Officer (United Nations Volunteer), under the oversight by 
the Deputy Regional Representative at ROMENA (D-1) and a Programme Officer (P3) at 
PTRS/DO, HQ. The project coordinator had a very strong relationship with all stakeholders 
involved in PSEY13.  
Interview and focus group data however revealed that the outputs of PSEY13 in terms of technical 
specifications, costings, facility systems, standards and operating protocols for the PNRC were 
adequate but only with the minimum required for start-up of the facility.  
For future operationalising of the facility it is therefore recommended to ensure ring fenced resources 
for ongoing staff and technical capacity, and maintenance support by the Palestinian MoH. This is 
necessary to support continued operation of the PNRC as it expands, support staff, and to 
adequately respond to anticipated patient demand for treatment in the West Bank. As it is only one 
centre serving the population in the West Bank, there is also a need to scale up over time with 
requirement for development of strong community rehabilitation support programme providing 
aftercare within a decentralised model.   
Summary - Efficiency 
PSEY13 utilized its resources efficiently to some extent to achieve its objectives, outputs in relation 
to the inputs and outcomes, with a strong governance structure.  
Delays in sign off from the MoH, and delays in starting the construction of the building in 
Bethlehem however led to corresponding delays in the project work plan, delayed recruitment of 
suitable clinical staff, and rescheduling of staff professional training activities.  
Outputs of PSEY13 in terms of technical specifications, costings, facility systems, standards and 
operating protocols for the PNRC were adequate for start-up of the facility, however for the future it 
is recommended to ensure ring fenced resources for ongoing staff and technical capacity, and 
maintenance support required by the Palestinian MoH. There is further a need for scale up over time 
and a requirement for development of strong community rehabilitation support programme 
providing aftercare within a decentralised model.   
Partnerships and cooperation 
Evaluation questions:  
➢ To what extent were the UNODC partnerships in Palestine efficient and effective with regard to the 
implementation of PSEY13? 
➢ To which extent did UNODC take advantage and maximize its impact while working with partners and 
other stakeholders (mainly working with WHO and the National Institute for Public Health)? 
➢ To what extent is partnering and cooperation with relevant stakeholders, governmental, CSOs and 
NGOs contributing to the functioning of the PNRC and its integration within the Palestinian health 
system? 
The evaluation showed that POPSE partnerships in Palestine were efficient, effective and integral to 
implementation of PSEY13. There was strong multi-disciplinary commitment and collaboration of 
key stakeholders across Ministries of Health, Interior, Social Affairs, Civil Police and Anti Narcotic 
Department, National Institute of Public Health, the National Programme on Drug Control, 
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Criminal Justice and Crime Prevention in supporting the project, and partnerships with the 
Methadone Centre, KOICA, National AIDS Committee and National High Committee for the 
Prevention of Drugs and Psychotropic Substances, but to a lesser extent the NGOs; Caritas, Al 
Maqdese and Al Sadiq al Tayyeb. All partners were identified from the beginning of the project.  
Interviews however revealed that the community NGOs Caritas, Al Maqdese and Al Sadiq al Tayyeb 
whilst having strong and positive relations with POPSE, were underutilised as information and 
support source in PSEY13, and are an untapped resource for future operations of the PNRC (and 
future similar projects), particularly given the need to decentralise drug treatment to primary care, and 
support patient rehabilitation in communities across the West Bank. It is therefore recommended to 
partner with and fully involve key NGOs as integral to the design and operation of future similar 
projects, or follow projects focusing on aftercare and rehabilitation in the community.   
Collaborations with the World Health Organisation (WHO), United Nations Development 
Programme (UNDP), United Nations Children's Fund (UNICEF), UN Women, and United Nations 
Relief and Works Agency (UNRWA) were further less developed in PSEY13. It is therefore 
recommended to further develop and include these international organisations in similar future 
projects to ensure their input, particularly given their expertise and the recognised complexities of 
drug abuse, gender violence, public and prison health, and key populations vulnerable to drug 
addiction and related health harms in the State of Palestine. 
Summary - Partnerships and cooperation 
POPSE partnerships in PSEY13 across Ministries, government, donor, national committees were 
efficient, effective and integral to PSEY13. It is however recommended to further strengthen 
partnerships with key NGOs, WHO, UNDP, UNICEF, UN Women and UNRWA in future 
projects to ensure their valuable input across health, children, gender and key populations. 
The NGOs Caritas, Al Maqdese and Al Sadiq al Tayyeb were underutilised in PSEY13. It is therefore 
recommended to partner with and fully involve key NGOs as integral to the design and operation of 
future similar projects, or follow projects focusing on aftercare in the community.  This is based on 
their experience in providing drug treatment and family support, and their trust within Palestinian 
communities.  
Effectiveness 
Evaluation questions:  
➢ To what extent did the PSEY13 achieve its planned results (objective and outcomes) and which 
unachieved results should be targeted in future projects? 
➢  To what extent did the implementation strategy of PSEY13 produce unintended outcomes (positive or 
negative)? 
➢ To what extent did PSEY13 support development of a comprehensive system of drug dependence 
treatment which is carefully established and integrated into the health system? 
➢ To what extent did PSEY13 strengthen institutional and human resource capacity to provide evidence 
based opioid substitution therapy and drug dependence treatment services at the PNRC? 
 
The evaluation shows that PSEY13 was effective in navigating challenges during implementation 
which centred on the continued political crisis affecting endorsement of the Drug Law, the non-
acceptance by the community of a drug centre leading to a change in location of the centre from 
Ramallah to Bethlehem, and difficulties in securing relevant and proper medical staff. These 
challenges contributed to delays in implementation timelines along 2016 (construction), 2017 
(construction and staff selection) and 2018 (provision of basic and advanced PNRC staff training) 
EVALUATION FINDINGS 
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with related project revisions. Detailed and ranked risks to PSEY13 implementation were also 
identified in project annual reports 2014-2018.  
Triangulation of data revealed that PSEY13 achieved its planned results, with the PNRC representing 
a starting point for the Palestine government in the establishment of a comprehensive system of drug 
dependence treatment and care fully integrated into their health system. Outputs were achieved and 
included staff capacity building, the 2017 situation assessments1516., treatment and service 
specifications and detailed cost analysis for staff and running costs at start-up of the PNRC.  PSEY13 
was however only effective to some extent in strengthening institutional and human resource 
capacity via foundation professional training, and in developing operating standards on evidence-
based drug treatment provision at the PNRC.  
Interview and focus group data revealed stakeholder concern around the PNRC operational 
standards. These were; 
• concerns regarding sufficient staffing levels (competency levels, patient staff ratio, security); 
• lack of consultation of staff in the building layout of the PNRC, and related risk 
identification (i.e. glass, windows).  
• lack of consultation of staff around operational planning (i.e. maintenance, security, waiting 
lists, dealing with high patient demand and re-admittance, support of community 
rehabilitation and reintegration).  
• concerns around the foundation professional training on drug dependence treatment 
provided by international expert trainers from outside Arab cultures.  
• lack of involvement of experienced general practitioners in primary care and key NGOs in 
supporting PNRC operations (i.e. staff training, patient referral and community rehabilitation 
pathways).  
It is recommended to improve effectiveness in future projects by consulting with staff, NGOs and 
experienced general practitioners in primary care, and in providing professional training specific to 
clinical professions by Middle Eastern experts. It is further recommended that operational standards, 
risk assessments and technical specifications include clinical staff input and contingency to respond 
to demand. 
Summary - Effectiveness 
PSEY13 achieved its planned results, with the PNRC representing a starting point for the Palestine 
government in the establishment of a comprehensive system of drug dependence treatment and care 
integrated into their health system.  
PSEY13 was effective only to some extent with strengthening institutional and human resource 
capacity via foundation professional training and developing operating standards as a starting point to 
provide evidence-based treatment at the PNRC. For future operational standards, risk assessments 
and technical specifications it is however recommended to include clinical staff input. 
There was further a lack of involvement of key experts, for example Middle Eastern clinicians, 
experienced general practitioners and key NGOs in staff training, and in establishing patient referral 
________ 
15 (UNODC/KOICA/WHO (2017). Illicit Drug Use in Palestine: A Qualitative Investigation Formative phase study report. 
Palestinian National Institute of Public Health, Ministry of Health, UNODC/KOICA/WHO occupied Palestinian 
Territory, November 2017.  
16 (UNODC/KOICA/WHO (2017). Estimating the Extent of Illicit Drug Use in Palestine Palestinian National Institute of 
Public Health, Ministry of Health, UNODC/KOICA/WHO occupied Palestinian Territory, November 2017. 
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and community rehabilitation pathways. It is therefore recommended to include such key experts and 
stakeholders in future projects.   
Impact 
Evaluation questions:  
➢ To what extent did PSEY13 contribute, or is likely to contribute to long-term impact and /or outcomes? 
➢ To what extent did PSEY13 contribute to achieving the related Sustainable Development Goals, 
particularly SDG3? 
➢ To what extent did PSEY13 contribute to UNODC’s Thematic Sub Programme 5 on Health and 
Livelihoods (Drugs and HIV) and contributes to the UNODC Regional Integrated Cooperation 
Programme for the occupied Palestinian Territory Programme on Drug Control, Crime Prevention and 
Criminal Justice Reform in the Arab States 2011-2015 (Sub Programme III Drug Prevention and Health: 
Outcome 4 and 16)? 
➢ To what extent did PSEY13 contribute to the key priorities of the United Nations Development 
Assistance Framework (UNDAF) for Palestine?  
➢ To what extent can the project’s impact be measured in terms of the training cohort analysis? 
 
The evaluation shows that PSEY13 supported the Palestinian government in developing its response 
to the identified rise in drug use and related risk behaviours1718 in the State of Palestine, by virtue of 
setting up the first drug treatment and rehabilitation centre of its kind, that is science, gender and 
human rights-based in place and fully integrated into the Palestinian health system.  
The PNRC opened in January 2019, i.e. after the evaluation field mission took place. Hence it is not 
possible to assess the true impact of PSEY13 in terms of how the PNRC will address needs 
pertaining to levels of drug activity and drug dependence in the State of Palestine, it’s long term 
impact and outcomes for the drug using Palestinian community and their affected family members, 
and long term impact on drug injecting related infectious diseases, drug related crime and drug 
related gender violence.  
Strong synergies and linkages of PSEY13 to the UN SDG 3 exist by virtue of its focus on ensuring 
healthy lives and promote well-being for all at all ages. This is given its remit to promote health and 
wellbeing of Palestinian people, tackle the rise in drug abuse in men, women and youth in the State of 
Palestine, and essentially when providing the service ‘leave no one behind’. PSEY13 was also strongly 
aligned with UNODC Thematic Programme on Health and Livelihoods (Drugs and HIV); Sub-
Programme 3 (Drug prevention and health) of UNODC Regional Programme on Drug Control, 
Crime Prevention and Criminal Justice Reform in the Arab States (2011-2015); Sub-Programme V 
(Prevention of Drug Use, Treatment and Care of Drug Use Disorders and HIV/AIDS Prevention 
and Care) of the last UNODC Regional Programme for the Arab States to Prevent and Combat 
Crime, Terrorism and Health Threats and Strengthen Criminal Justice Systems in Line with 
International Human Rights Standards (2016-2021). It is also strongly aligned with the UNODC 
global programme GLOK32 and operated alongside UNODC programmes and projects such as 
PALI06; XNAJ58, XAMW59 and PSEX0219. 
________ 
17 (UNODC/KOICA/WHO (2017). Illicit Drug Use in Palestine: A Qualitative Investigation Formative phase study report. 
Palestinian National Institute of Public Health, Ministry of Health, UNODC/KOICA/WHO occupied Palestinian 
Territory, November 2017.  
18 (UNODC/KOICA/WHO (2017). Estimating the Extent of Illicit Drug Use in Palestine Palestinian National Institute of 
Public Health, Ministry of Health , UNODC/KOICA/WHO occupied Palestinian Territory, November 2017. 
19 GLOK32 UNODC-WHO Programme on Drug Dependence Treatment and Care. 
XNAJ58: Promoting good practices and networking to reduce demand for and harm from drugs. 
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Through setting up of the PNRC as an evidence based drug treatment centre integrated within the 
Palestinian health system, and the capacity building of its staff, PSEY13 contributed to key priorities 
of the 2018-2022 United Nations Development Assistance Framework (UNDAF) for Palestine and 
relevant sector and cross-sector strategies of the Palestinian Government (National Health Strategy 
2017-2022, National Programme on Drug Control, Crime Prevention and Criminal Justice Reform in 
the State of Palestine, 2014-2017, the PRDP, National Policy Agenda (2017-2022), national cross-
sectoral Gender strategies, and National Juvenile Justice strategy).  
Summary - Impact 
PSEY13 supported the Palestinian government in developing its response to identified rising drug 
use and related risk behaviours2021 in Palestine, by virtue of setting up the PNRC which is its first 
drug treatment and rehabilitation centre fully integrated within their health system.  
PSEY13 further had strong synergies with UN SDG 3 (ensuring healthy lives and promote well-
being for all at all ages). It had strong alignment with global and regional UNODC programmes; and 
key regional priorities identified in policy frameworks for the State of Palestine.  
It was however not possible to assess long-term impact of PSEY13 or how the PNRC will address 
needs pertaining to levels of drug activity and drug dependence in the State of Palestine as the PNRC 
opened only after the evaluation field mission took place.  
Sustainability 
Evaluation questions:  
➢ To what extent are the results of PSEY13 generated through its activities likely to continue in Palestine 
after the project completion? 
➢ To what extent has UNODC assistance helped to generate commitment of the health sector actors in 
the provision of a comprehensive rehabilitation treatment to continue even after completion of the 
project? 
➢ To what extent is ownership important to the sustainability of cascade of training? 
➢ To what extent are donors or national resource allocation required to support the running costs of the 
PNRC so that they can provide free of charge services and purchase medications, health consumables or 
furniture? 
 
The evaluation showed that POPSE technical assistance had through its activities in PSEY13 
supported the generation of governmental commitment to support the operation of the PNRC. The 
PNRC became operational by the Palestinian MoH in January 2019. Potential threats identified by 
the evaluation to sustainability relate to the requirement for continued governmental funding to 
support the running of the facility (i.e. medicines procurement, staffing and maintenance costs) itself 
                                                                                                                                                              
PSEX02: Forensic Human Resource and Governance Development Assistance for the Palestinian Authority. 
PALI06: Drug Control and related crime cooperation programme between the Palestinian Authority and UNODC for the 
prevention of drug abuse, drug trafficking and related criminal activities. 
XAMW59: Improving Prevention and Criminal Justice Response to Violence against Women and Girls in the MENA 
Region. 
20 (UNODC/KOICA/WHO (2017). Illicit Drug Use in Palestine: A Qualitative Investigation Formative phase study report. 
Palestinian National Institute of Public Health, Ministry of Health, UNODC/KOICA/WHO occupied Palestinian 
Territory, November 2017.  
21 (UNODC/KOICA/WHO (2017). Estimating the Extent of Illicit Drug Use in Palestine Palestinian National Institute of 
Public Health, Ministry of Health , UNODC/KOICA/WHO occupied Palestinian Territory, November 2017. 
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and the need to budget for scale up across the West Bank via decentralisation and provision of an 
aftercare programme. . 
Ownership is vital to the cascade of clinical training, and with further ongoing professional training, 
mentoring and peer training identified by stakeholders as key to supporting sustainability of PSEY13 
outcomes. Future projects are recommended to provide and support further technical assistance 
pertaining to clinical training and staff mentoring by Middle Eastern experts and the twinning of the 
PNRC with a leading UK treatment centre.  
Summary - Sustainability 
PSEY13 generated governmental commitment to support the continued operation of the PNRC. 
Potential threats to sustainability of PSEY13 achievements however relate to requirement for 
governmental funding to support operations of the PNRC.   
Future projects are recommended to provide further technical assistance to include clinical training 
and mentoring by Middle Eastern experts, and the twinning of the PNRC with a leading UK 
treatment centre. 
Sustainability of the PNRC hinges on the support of decentralisation and scale up of referral, 
treatment and rehabilitation using primary services and NGO across the West Bank.   
Human Rights, Gender Equality and leaving no one behind 
Evaluation questions:  
➢ To what extent were human rights considerations included in the design and implementation of 
PSEY13? 
➢ To what extent have human rights principles been considered by the PNRC staff to deal with drug users 
in project outputs ie SOPS, treatment service specifications? 
➢ To what extent was PSEY13 relevant to the needs and priorities as defined by beneficiaries, women and 
girls? 
➢ To what extent were gender aspects considered; for example, were female quotas achieved in the 
training of females? 
➢ To what extent were under-represented and vulnerable groups among drug users included in the design 
and implementation of PSEY13? 
➢ To what extent has PSEY13 answered the service needs of vulnerable targeted groups? 
➢ Are there any key vulnerable groups of drug users identified which may not access the PNRC? 
➢ To what extent does the care planning system of the PNRC prevent loss to follow up and treatment 
drop out? 
 
Human Rights 
Changes in Palestinian society and awareness of health rights of those addicted to substances prior to 
PSEY13 were as follows.  
• The Right to Health was included in the Palestinian Drug Law which states the drug addict is 
a patient and should have the opportunity to access treatment services;  
• The National High Committee for the Prevention of Drugs and Psychotropic Substances 
recognizes drug dependence as a multi-factorial health disorder; 
• Addressing drug dependence as a disease was highlighted in the Palestinian National Health 
Strategy 2011 –2013.  
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Triangulation of data reveals that human rights considerations were to some extent considered in the 
design and implementation of PSEY13. The PNRC provides voluntary treatment services free of 
charge and will not provide compulsory drug dependence treatment or treatment offered as part of a 
community sentence and other probation orders.  
Training modules incorporated human rights principles within evidence-based treatment modalities, 
which include right to treatment, right to confidentiality, treatment according to international 
standards and guidelines, and alternatives to incarceration. Some concerns were however voiced 
during stakeholder interviews that the foundation professional training to a lesser degree facilitated 
discussion around medical ethics within the Middle East concerning authoritarian or paternalistic 
approaches to treatment coercion (for example families signing family members into compulsory 
treatment; court referrals). It is therefore recommended to include such Middle Eastern ethical, 
gender and human rights considerations in future trainings.  
 
Gender Equality 
 
Triangulation of data reveals that gender mainstreaming was to some extent considered in PSEY13. 
Firstly, gender quotas were achieved in the training of PNRC staff. Secondly, the PNRC operations 
by providing a dedicated floor (with separate elevator) for female inpatients considered treatment 
stigma for women and girls, the unique drug use and dependence characteristics of women, and their 
unique treatment needs. Stakeholders during interviews however observed the need for further 
development of gender responsive drug treatment (i.e. home detoxification for women and girls) and 
better linkage to gender violence services in the community, and this is therefore recommended for 
future projects. In addition, strategic information and data surveillance at the PNRC to include 
disaggregation by sex would also be required. 
 
Interview and focus group data further revealed that PNRC staff will require additional follow-up 
gender specific professional training on the needs of opiate dependent pregnant women (and opiate 
dependent neonates), and will need training around the development of dedicated referral 
mechanisms for women affected by gender-based violence. It is therefore recommended to include 
these aspects in future professional training as well as development of programmes. 
 
 
Leaving no one behind 
  
Interview and focus group data indicate that PSEY 13 contributed to the UNDAF Strategic Priority 
Area 4, stating that “All Palestinians, especially the most vulnerable who are often left behind, have access to quality 
services, including health and education and social protection systems, such as social insurance.”  Whilst the PNRC is 
open to all who require treatment for drug abuse, several key populations were however identified 
during interviews and focus groups as requiring further outreach, and treatment programming 
specificity by the PNRC, including children of substance using families; girls affected by sexual 
violence; Palestinian youth (particularly those living in camps, in Area C); the Bedouin groups; 
prisoners; physically and mentally disabled; patients with HIV/tuberculosis/Hepatitis C co-infection; 
patients with co-morbid or dual diagnosis, and pain patients with iatrogenic opioid dependence; 
choices in OST (i.e. low threshold buprenorphine naloxone); and, behavioural addictions relating to 
technologies.  
It is therefore recommended to include and consider these key populations in future training and 
treatment programming.  
Summary - Human Rights, Gender Equality and leaving no one behind 
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Human Rights 
 
Human rights considerations were to some extent included in the design and implementation of 
PSEY13. Training modules incorporated human rights principles within evidence-based treatment 
modalities however to a lesser degree facilitated discussion around medical ethics concerning 
authoritarian or paternalistic approaches to treatment coercion. It is therefore recommended to 
include specific Middle Eastern ethical and human rights considerations in future facility design and 
design of staff trainings, particularly around treatment coercion by families. 
 
Gender Equality 
 
Gender mainstreaming was to some extent included in PSEY13 which achieved the female gender 
quote of training and considered the unique drug use and dependence characteristics of women in 
the PNRC. It is however recommended to support ongoing gender specific professional training on 
the needs of drug dependent pregnant women (and opiate dependent neonates), further develop 
gender responsive drug treatment programmes, and develop dedicated referral mechanisms for 
women affected by gender-based violence. 
 
Leaving no one behind  
 
Several key populations were identified as requiring further outreach and programming specificity by 
the PNRC, alongside specific clinical training for staff. These included family support of children 
affected by familial substance abuse, girls affected by sexual violence, minority groups such as the 
Bedouin and prisoners, and patients with co-infection and co-morbidities. 
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III. CONCLUSIONS  
The unique socioeconomic context in the West Bank is characterized by political and economic 
tensions and has created conditions that facilitate the spread of illicit, novel psychoactive and 
prescription drug trafficking, use and abuse among Palestinians (men, women, youth and within 
families). 
Prior to the implementation of PSEY13, Palestine lacked a comprehensive system of drug 
dependence treatment and care fully integrated into the health system. This was further hampered by 
the limited knowledge of health professionals on addictions and the treatment of drug dependence, 
lack of applicable research-based evidence, and limited financial and human resources. The PNRC 
was the first centre of its kind in Palestine and has operated since January 2019. 
PSEY13 by virtue of setting up the first evidence and human rights-based drug treatment facility in 
Palestine and responding to the need for drug dependence treatment, strongly contributes to the 
UNDAF Strategic Priority Area 4. This states that “All Palestinians, especially the most vulnerable who are 
often left behind, have access to quality services, including health and education and social protection systems, such as 
social insurance.”   
PSEY13 achieved its objectives in terms of strengthening governmental capacity to provide evidence 
and human rights-based drug dependence treatment and rehabilitation; building human resource 
capacity in providing evidence and human rights-based drug treatment and providing research-based 
evidence through situational assessments2223. PSEY13 had strong synergies and linkages with UN 
SDG 3, focusing on ensuring healthy lives and promote well-being for all at all ages, and had strong 
alignment with global and regional UNODC programmes; and key regional priorities identified in 
policy frameworks for the State of Palestine.  
POPSE partnerships with donor, international organisations, Ministries and NGOs in Palestine were 
efficient, effective and integral to implementation of PSEY13, however requiring further 
strengthening of partnerships with key NGOs, WHO, UNDP, UNICEF, UN Women and UNRWA 
in future similar projects to ensure their valuable input given the interplay between drug abuse, and 
gender violence, public and prison health, and key populations vulnerable to drug addiction and 
related health harms. 
Project revisions were incurred due to a change in designated location of the PNRC originally 
planned for Ramallah. Delays in sign off from the MoH, and delays in starting the construction of 
the building in Bethlehem led to corresponding delays in the project work plan, delayed recruitment 
of suitable clinical staff, and rescheduling of staff professional training activities, making the project 
only to some extent efficient. 
________ 
22 (UNODC/KOICA/WHO (2017). Illicit Drug Use in Palestine: A Qualitative Investigation Formative phase study report. 
Palestinian National Institute of Public Health, Ministry of Health, UNODC/KOICA/WHO occupied Palestinian 
Territory, November 2017.  
23 (UNODC/KOICA/WHO (2017). Estimating the Extent of Illicit Drug Use in Palestine Palestinian National Institute of 
Public Health, Ministry of Health, UNODC/KOICA/WHO occupied Palestinian Territory, November 2017. 
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The design of PSEY13 based on a bi-lateral agreement between MoH and KOICA in constructing 
and equipping the facility was not without problems, with discrepancies reported in final technical 
and equipment specifications and 12-month work plans. There was a distinct lack of PNRC staff, 
experienced general practitioner and NGO consultation in the design, planning, technical 
specification, facility risk assessment and operation of the PNRC itself. NGOs, Middle Eastern 
clinical experts and experienced general practitioners were under-utilised in staff capacity building, all 
of whom have significant relevant experience.  
Design of professional foundation training on addictions and drug dependence treatment whilst 
useful, was generic to the PNRC staff as a collective, with suggested improvements based on the 
preference of profession specific clinical training, practice-based education and mentoring delivered 
by Middle Eastern experts who have experience of the cultural, ethical and gendered complexities of 
drug abuse and treatment in the Arab world. 
Human rights and gender mainstreaming was to some extent adequate in staff training and PNRC set 
up, but with several key populations requiring further attention, such as children of substance using 
families, girls affected by sexual violence; Palestinian youth (Area C), the Bedouin groups, prisoners, 
physically and mentally disabled, patients with HIV/TB/Hepatitis C co-infection, patients with co-
morbid or dual diagnosis, pain patients with iatrogenic opioid dependence, and as a future identified 
risk, the presence of behavioural addictions relating to technologies.   
Impact of PSEY13 cannot be assessed due to the delayed start-up of the PNRC. In order to sustain 
the achievements of PSEY13 in terms of staff capacity, cascade of training and operationalisation of 
the facility itself, the PNRC requires ring fenced governmental resources for ongoing clinical training, 
education and mentoring of tis staff, operations and maintenance support. Decentralisation of the 
service may be supported by a future aftercare project supporting community rehabilitation and 
reintegration across the West Bank.  
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IV. RECOMMENDATIONS  
Technical Assistance  
 
Finding: There was a lack of PNRC staff, general practitioner and NGO consultation in the 
design, technical specifications, standards and systems in supporting operationalisation of the 
PNRC as a facility, which requires the operational support of decentralisation and scale up of 
community referral and rehabilitation using primary services and NGOs across the West Bank.  
Recommendation 1 - Improve the design, technical specifications, standards and clinical 
systems of future similar projects such as a follow up community referral and rehabilitation 
aftercare project, by consulting with and involving Middle Eastern clinical experts, PNRC staff, 
experienced general practitioners, and NGOs (Project management, UNODC Programme 
Office in the State of Palestine) 
 
Training Activities  
 
Finding: The design of professional training for PNRC staff was only at the foundation level, 
delivered to all clinical professions solely in English as a collective training, did not fully regard 
Middle Eastern gender, cultural and ethical aspects of drug abuse and drug treatment, or utilise 
existing expertise from community NGOs, experienced general practitioners and Middle 
Eastern clinical experts.  
Recommendation 2 - Improve the design and clinical and cultural applicability of professional 
training in future projects by delivering training that is specific to each clinical discipline, that 
includes Middle Eastern gender, ethical and human rights considerations, and that is provided 
by Middle Eastern clinical and NGO experts (Project management, UNODC Programme 
Office in the State of Palestine)  
Sustainability  
 
Finding: The PNRC only became operational by the Palestinian MoH in January 2019. 
Potential threats to sustainability relate to the requirement for continued governmental funding 
to support staff capacity building, commitment and the running of the facility. 
Recommendation 3 - Ensure that future similar projects have sufficient financial resources to 
support sustainable operations, via e.g. 12-month work planning and ring-fenced resources for 
maintenance, patient demand and staff support. (Project management, UNODC Programme 
Office in the State of Palestine) 
 
Partnerships and Cooperation  
 
Finding: POPSE partnerships in Palestine were efficient, effective and integral to 
implementation of PSEY13. There was strong multi-disciplinary commitment and 
collaboration of relevant key stakeholders. The NGOs Caritas, Al Maqdese and Al Sadiq al 
Tayyeb were however underutilised and collaborations with WHO, UNDP, UNICEF, UN 
Women, and UNRWA were less developed.  
Recommendation 4- Engage with all relevant stakeholders (country partners, Ministerial, 
health professionals and NGOs) and further develop existing collaborations with WHO, 
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UNDP, UNICEF, UN Women, and UNRWA in future similar projects. (Project management, 
UNODC Programme Office in the State of Palestine and UNODC Regional Office for Middle 
East and North Africa) 
Human Rights 
 
Finding:  Human rights considerations were only to some extent included in the design and 
implementation of PSEY13. 
Recommendation 5 - Ensure human rights are considered and respected in the provision of 
voluntary drug treatment access and provision in future similar projects. (Project management, 
UNODC Programme Office in the State of Palestine) 
Gender Mainstreaming and Leaving No one Behind  
 
Finding: Gender mainstreaming was only to some extent adequately included in PSEY13, 
which achieved the female gender quote of staff training, and considered the unique drug use 
and dependence characteristics of women in the design of PNRC facility. Needs of opiate 
dependent pregnant women, girls affected by sexual violence, and key vulnerable groups were 
however not fully considered. Further training is also required on drug dependence during 
pregnancy and after delivery.  
Recommendation 6 - Recognise and respond to the needs of identified key vulnerable 
populations in future similar projects (Project management, UNODC Programme Office in the 
State of Palestine) 
 
Staffing  
 
Finding: PSEY13 was operated by a small team of three staff at POPSE with a strong 
governance structure supported by ROMENA and HQ. PSEY13 however was dependent on 
the efforts of this small team of staff, and in particular, dependent on the very strong and 
positive relationships the project coordinator had developed with all stakeholders involved in 
PSEY13. 
Recommendation 7 - Ensure sufficient project staffing capacity to support all aspects of pre-
assessment, design, planning and implementation of future similar projects. (Project 
management, UNODC Programme Office in the State of Palestine and UNODC Regional 
Office for Middle East and North Africa) 
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V. LESSONS LEARNED AND BEST 
PRACTICES 
Evaluation questions:  
➢ Which were the lessons and best practices that the UNODC Project Team should use and follow up 
upon for a possible new project focusing on the provision of aftercare? 
➢ How can a new follow on project linked to the PNRC strengthen the gains made by PSEY13?  
 
Risks prior to the implementation of PSEY13 implementation included vulnerability to political 
instability, risk to staff security, compromised delivery of activities due to lack of access, transport, 
road blocks or poor infrastructure, delays in recruitment of suitable staff, dependence of OST 
provision and equipment procurement on Israeli permits.  Mitigation measures centred on strong 
cooperation with the national authorities and identification of alternative solutions for training 
outside Palestine; close monitoring of circumstances in the field; ensuring that the PNA was fully 
involved in the implementation of the programme; local procurement and working closely with 
relevant authorities to ensure timely customs clearance of equipment and medicines.   
The detailed and comprehensive process of risk identification and mitigation, and how challenges in 
operations were overcome (for example. overcoming community resistance in location of the PNRC 
by moving to Bethelehem, difficulties in recruiting competent clinical staff and requirement for 
supportive buy in from health care providers by working closely with the PNA) can contribute to 
lessons learnt for future similar programme implementation.  
Lessons learnt throughout implementation of PSEY13 centred on the importance of fully involving 
all stakeholders, government partners, NGOs, experienced general practitioners, PNRC staff, Middle 
Eastern clinicians, donors and international organisations through the projects inception, design and 
implementation. Given the potential for community resistance to location of a drug treatment centre, 
the potential for difficulties in recruiting of clinical staff willing to work with drug users, and the 
requirement for supportive buy in from health care providers, community organisations and primary 
care networks to support patient referral and community rehabilitation, this is paramount to consider 
in future projects.  
Best Practices identified in PSEY13 centre on the defining of facility technical specifications, 
standards, mission statement, risk assessments, systems and SOPs for start-up of the PNRC.  These 
can be applicable to other drug treatment facility projects in the region.  
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ANNEX I.  TERMS OF REFERENCE OF THE 
EVALUATION 
Final Independent Project Evaluation 
“Supporting the establishment of evidence-based 
drug dependence treatment and rehabilitation 
system for the Palestine National Rehabilitation 
Centre”  
 
PSEY13 
 
 
 
 
 
 
 
State of Palestine  
(West Bank) 
June 2018
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Background and Context  
Project number: PSEY13 
Project title: Supporting the establishment-based drug dependence 
treatment and rehabilitation system for the Palestine 
National Rehabilitation Centre 
Duration (dd/mm/yyyy-dd/mm/yyyy): 31/01/2014-31/12/2018 
Location: Palestinian Territories, West Bank 
Linkages to Country, Regional and 
Thematic Programmes: 
Sub-Programme 3 (Drug Prevention and Health) of the 
UNODC Regional Programme on Drug Control, Crime 
Prevention and Criminal Justice Reform in the Arab 
States (2011-2015)  
 
Sub-Programme 5 of the UNODC Strategic Framework 
for the period 2014-2015.  
 
UNODC Thematic Programme on health and 
livelihoods (Drug and HIV).  In particular, the project 
relates to “expected accomplishment (a)”: “Increased 
implementation at the national level of evidence-
based services related to drug use in the community”. 
To which UNDAF24 is the 
project/programme linked to (if any) 
UNDAF Strategic Priority Area 4: Leaving No One 
Behind: social development and protection 
Executing Agency: UNODC 
Partner Organizations: None 
Total Approved Budget: $622,913.00 
Total Overall Budget $622,913.00 
Donors: Korea International Cooperation Agency (KOICA) 
Project Manager/ Coordinator: Mr. Khaldoun Oweis, National Project Manager and 
________ 
24 United Nations Development Assistance Framework. 
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Officer in Charge, UNODC Programme Office in the 
State of Palestine (POPSE) 
Type and time frame of evaluation: 
(Independent Project Evaluation/In-
depth Evaluation/mid-term/final) 
Final Independent Project Evaluation (July – December 
2018) 
Time frame of the project covered by 
the evaluation: 
January 2014 (beginning of the project) - September 
2018 (end of field mission) 
Geographical coverage of the 
evaluation:  
Palestinian Territories (West Bank - (mainly Ramallah, 
Bethlehem) ) 
Budget for this evaluation in USD: $20,000 
Number of independent evaluators 
planned for this evaluation25:  
1 independent evaluator 
Type and year of past evaluations (if 
any):  
None 
 
Core Learning Partners26 (entities): Ministry of Health, Korea International Cooperation 
Agency (donor), medical staff from public hospitals and 
methadone centres, World Health Organization, the 
Palestinian National Institute of Public Health 
________ 
25 Please note that the minimum for any UNODC evaluation is two independent evaluators, i.e. one lead evaluator 
and one team member.  
26 The CLPs are the main stakeholders, i.e. a limited number of  those deemed as par ticularly relevant to be 
involved throughout the evaluation process, i.e. in reviewing and commenting on the TOR and the 
evaluation questions, reviewing and commenting on the draft evaluation report, as well as facilitating the 
dissemination and application of  the results and other follow-up action. Stakeholders include all those to be 
invited to participate in the interviews and surveys, including the CLPs.  
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Project overview and historical context  
The United Nations Office on Drug and Crime (UNODC) has been providing technical assistance to 
the State of Palestine since 2005. It started with programmes on drug prevention, with the 
development and implementation of HIV prevention and care strategies among drug users in the 
West bank and Gaza through the established drop-in centres. The office extended the areas of 
technical assistance and focused on strengthening the Palestinian justice system.  
 
In the Palestinian National Policy Agency (PNPA), which forms part of the Palestinian Reform and 
Development Plan 2008-2010 (PRDP), the Palestinian National Authority (PA) states that quality of 
life is one of four national policy goals towards which their actions must lead. The PRDP determines 
that a strengthened social coherence and solidarity, matched with improved quality of health services, 
is a high-level objective for the PRDP period so that the most vulnerable areas and groups in society 
continue are supported and the culture, national identity and heritage of the Palestinian people are 
reinforced. It is further stated that “increased capacity of public sector organization involved in social 
policy making, provision of well-targeted social assistance, and the delivery of basic education and 
health services will have a direct positive effect on the daily lives of citizens.” This is also part of the 
Strategic Objectives for the Health Sector indicating that the Ministry of Health (MoH) should make 
efforts towards “achievement of the best possible outcomes from health care services.” 
In 2009, UNODC supported the National High Committee for Drugs in the development of a 
National Drug Strategy for 2009-2011 and a Drug dependence treatment and Rehabilitation 
Protocol. Meanwhile, the MoH identified a serious lack of technical and human resource capacity on 
evidence-based assessment, diagnosis and treatment of drug dependence as a major weakness in its 
health system. Moreover, no proper structure for drug dependence treatment and rehabilitation was 
existing in the State of Palestine. 
In view of a perceived increase in the number of drug users and the high demand for drug 
dependence treatment, the MoH requested support to set up a governmental treatment and 
rehabilitation centre in the West Bank. In 2012, the Korea International Cooperation Agency 
(KOICA) answered to this request and signed an agreement with the MoH for the establishment of 
the first Palestine National Rehabilitation Centre (PNRC) for a total amount of $5,000,000. UNODC 
was also requested to provide support to the MoH to build its capacity to offer a proper structure for 
drug users.  
The project “Supporting the establishment-based drug dependence treatment and rehabilitation 
system for the Palestine National Rehabilitation Centre” (PSEY13) was designed based on the 
request of the MoH and UNODC previous experience in the West Bank, addressing the capacity 
needs and governance aspects of an assistance package to contribute to the development of a 
comprehensive system of drug dependence treatment and care, fully integrated into the Palestinian 
health system. It was also designed to ensure the strengthening of the institutional and human 
resource capacity of the PNRC to be established, through the provision of a comprehensive package 
of drug dependence treatment and rehabilitation services with continuum of care through 
community-based services. The project was officially launched in 2014 and is about to end in 
December 2018. 
The project is funded by KOICA and has been implemented by the UNODC Programme Office in 
the State of Palestine (POPSE) in partnership with the Palestinian MoH. 
The key element of the project is to ensure the provision of trainings and awareness raising on 
evidence-based drug dependence treatment as a multifactorial chronic disease with a focus on the 
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relationship between the drug conventions and human rights. Efforts have been undertaken to 
ensure that the right to health is included in the draft of the Palestinian Drug Law. Furthermore, each 
outcomes of the project contributes to the establishment of a comprehensive system of drug 
dependence treatment, strengthening institutional and human resources capacity, including the right 
to enjoyment of the highest attainable standard of physical and mental health.  
The gender mainstreaming strategy was driving the design of the project and its outcomes in 
different ways. Part of the project goal consist in ensuring that national strategies promote gender-
responsive services for women, with the development and implementation of standards/guidelines 
for gender-responsive services. Provision of home-based detoxification and community-based 
services which are less stigmatizing to women are part of the services offered by the PNRC.  
Main challenges during implementation 
Political crisis 
One of the main challenges faced during the preparation and implementation concerned the political 
crisis in which the Palestinian authority is deeply mired. Since 2007, and the political division between 
Fatah and Hamas, the Palestinian Legislative Council is paralyzed. Only urgent laws according to the 
Palestinian Basic Law can be approved by the president. This has affected the endorsement of the 
Drug Law. In this matter, the draft Drug Law has been submitted to the General Secretariat of the 
Council of Ministeries and approved by presidential decree.  
 
Acceptance by the community  
The construction work of the PNRC was supposed to start in Ramallah in 2014, in order to have an 
operational centre during the first quarter of 2016. The non-acceptance by the community of a centre 
for drug users adversely impacted project implementation. Before the start of the construction, the 
community exerted pressures to prevent the PNRC from being established in the chosen location. 
Due to the rejection by the community, the chosen location of the centre had to be changed. The 
PNRC was moved from Ramallah to Bethlehem where the MoH owns a land beside the health 
directorate. The construction was delayed and thus the opening.  
 
Staff competencies 
Another challenge faced by UNODC during the implementation of the project is the difficulty to 
find and select qualified and experienced staff to be trained and operate the centre. Important delays 
occurred due to the difficulties of finding the relevant and proper medical staff. The MoH finalized 
the list of selected staff by the end of May 2018 to be trained few months before the opening of the 
PNRC.  
 
Project documents and revisions of the original project document 
 Year Please provide general information regarding the 
original project document. 
Project document 2013 The first project document submitted was approved on 
December the 18th, 2013. This document includes the 
results of a rapid assessment of healthcare services in 
the West Bank and the capacity of the MoH to 
respond to the needs of drug users. The original 
project document also includes a description of 
UNODC strategy in the Palestinian Territories, the 
partnerships and synergies, the project objectives, 
outcomes, outputs and activities planned. It also details 
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the therapeutic services to be provided by the PNRC, 
including short term treatment, case-management, 
community based-detoxification, psychosocial 
intervention, etc. The project documents also go 
through the legal context of the project, the detailed 
budget and the logical framework.   
 
Project 
revision27  
Year Reason & purpose (max. 2 sentences per revision) Change in (please 
check) 
1 2016 The project revision aims to increase the project 
duration to compensate the delay in starting the 
construction which led to corresponding delays in the 
project workplan.  
 Budget  
X Timeframe 
 Logframe 
2 2017 The goal of this project revision was to allow for the 
completion of activities as agreed upon under the 
developed project work plan. Delays in construction 
work and staff selection led to corresponding delays in 
the project workplan.  
 Budget  
X Timeframe 
 Logframe 
3 2018 The project revision is in response to the delays 
encountered to provide the basic and advanced training 
to the staff who operates the PNCR. The no-cost 
extension of the project will also allow for the conduct 
of a final Independent Project Evaluation.  
 Budget  
X Timeframe 
 Logframe 
 
Main objectives and outcomes  
The overriding objective of the project is to contribute to the development of a comprehensive 
system of drug dependence treatment and care, fully integrated into the health system and 
strengthening the institutional and human resource capacity of the PNRC. The model for all the 
healthcare services provided to drug users developed under the project is internationally accepted 
best practices. Upon completion, the Palestinian people will have access to drug dependence 
treatment and rehabilitation services with continuum of care through community-based services.  
 
UNODC assistance to the MoH follows the Action Plan for the Implementation of the Declaration 
on the Guiding Principles of Drug Demand Reduction: 1) facilitating information sharing on best 
practices/strategies, 2) providing guidance and assistance for the development of drug demand 
reduction strategies and programmes in line with the guiding principle of drug demand reduction and 
3) providing assistance for the establishment of national information system, including data on 
regionally and internationally recognized core indicators. 
 
Therefore, the following outcomes have been designed:  
Outcome 1: a comprehensive system of drug dependence treatment and rehabilitation that is science- 
and human rights-based in place and fully integrated into the Palestinian health system.  
________ 
27 Please add further rows as needed.  
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Outcome 2: a package of integrated and voluntary drug dependence treatment and rehabilitation 
services that are gender sensitive, science- and human rights- based is made available at the Palestine 
National Rehabilitation Centre.  
 
Objective of the project/programme (as per project document/revision): 
Objective: Supporting the provision of evidence-based drug dependence treatment and 
rehabilitation system for the Palestine National Rehabilitation Centre.  
 
This objective can be broken down into two sub-objectives, including (i) the 
establishment of a comprehensive system of drug dependence treatment and 
care, (ii) its integration into the health system with strengthened institutional 
and human resource capacity to provide evidence-based opioid substitution 
therapy and drug dependence treatment at the PNRC.   
Performance 
indicators:  
The performance indicators are (i) approval of standard operating procedures 
for treatment protocol; (ii) approval of National OST operational guideline; (iii) 
percentage of people accessing opioid substitution therapy and other drug 
dependence treatment services offered by the national treatment centre (m/f, 
type of drug, mode of assumption).  
 
 
Outcomes of the project/programme (as per project document/revision)28 
Outcome 1: A comprehensive system of drug dependence treatment and rehabilitation that is 
science- and human rights-based in place and fully integrated into the Palestinian 
health system 
Performance 
indicators:   
-Endorsement of Standard Operating Procedures for Treatment Protocol; 
-Palestinian National Treatment Centre’s mission statement, strategic 
management and governance plan, core policies and care planning developed.  
Outcome 2: A package of integrated and voluntary drug dependence treatment and 
rehabilitation services that are gender sensitive, science- and human rights- based 
is made available at the Palestine National Rehabilitation Centre 
Performance 
indicators: 
-Availability of OST, involving the use of opioid agonists for maintenance 
treatment of opioid dependence; 
-Number of all individuals (m/f) on OST 6 months after PNRC opening; 
-Number of all individuals (m/f) receiving inpatient drug detoxification during the 
first 6 months from the opening of the centre.  
 
Contribution to UNODC’s country, regional or thematic programme 
Contribution to the following UNODC country and regional programmes:  
 
________ 
28 Please delete or add rows below as needed for the different outcomes.  
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1. The Palestinian Reform and Development Plan (PRDP)29 determined that the increased 
capacity of public sector organizations involved in social policy making – including the MoH 
– should provide well-targeted social assistance. It is further stated that “the delivery of … 
health services will have a direct positive effect on the daily lives of citizens.” The objectives 
in this regard are further defined in the National Health Strategy (2017-2022)30 and also 
include the development of expertise on matters relating to healthcare services. As part of 
the strategic objectives, it is stated that the State of Palestine should “ensure the provision of 
comprehensive health services to all Palestinians, heading towards localization of health 
services.” In June 2014, the Palestinian National Authority officially launched, with the 
support of UNODC, a National Programme on Drug Control, Crime Prevention and Criminal Justice 
Reform in the State of Palestine, 2014-2017, which brings current and future project activities 
into a broader programmatic framework covering drug control, crime prevention and 
criminal justice reform.  
 
2. During the project implementation, the Palestinian Authority finalised the Palestinian 
National Policy Agenda (NPA) for 2017-2022. It articulates a set of priorities aiming at 
directing international support to the Palestinian Authority under the umbrella of three main 
pillars: a Path to Independence, Government Reform, and Sustainable Development. It also 
identifies 29 national policies to achieve these goals, putting “citizens first” and outlining 
Government priorities aligned with the Sustainable Development Goals and Agenda 2030 
premises to “leave no one behind.” Through the NPA, the Palestinian Authority reiterates its 
commitment to state-building government, long-term institutional development and quality 
health care for all (national priority 9). Therefore, the project “Supporting the 
Establishment-based Drug Dependence Treatment and Rehabilitation System for the 
Palestine National Rehabilitation Centre” directly supports the Palestinian Authority in 
meeting its commitment and in providing quality health care services to the Palestinian 
people.  
 
3. The contribution of the project to UNODC Regional Programme and Thematic Programme 
is operationalised through three main components, namely: diversified quality and cost-
effective treatment services to drug dependent persons; raised capacity in treatment, 
rehabilitation and reintegration of drug users; and standardized drug dependence treatment 
manuals and training programmes.   
 
4. The project relates to Sub-Programme 3 (Drug prevention and health) of the UNODC 
Regional Programme on Drug Control, Crime Prevention and Criminal Justice Reform in 
the Arab States (2011-2015) that was developed in partnership with the League of Arab 
States. The Regional Programme covers three priorities areas: (i) countering illicit trafficking, 
organized crime and terrorism, (ii) promoting justice and building integrity and (iii) drug 
prevention and health. The overall goal of the Regional Programme is to support the efforts 
of Member States in the region to respond to evolving threats, with a focus on achieving 
clear outcomes with a tangible impact. An objective of Sub-Programme 3 is to assist States 
in the Arab region in setting general framework for national and regional drug demand 
reduction strategies, as well as in enhancing and promoting drug treatment and rehabilitation 
programmes with UNODC assistance. The project outcomes are aligned with Sub-
________ 
29 Online: http://siteresources.worldbank.org/INTWESTBANKGAZA/Resources/PRDP08-10.pdf  
30 Available online: http://www.lacs.ps/documentsShow.aspx?ATT_ID=29996  
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Programme 1. The project also relates to the Sub-Programme V (Prevention of Drug Use, 
Treatment and Care of Drug Use Disorders and HIV/AIDS Prevention and Care) of the 
last UNODC Regional Programme for the Arab State to Prevent and Combat Crime, 
Terrorism and Health Threats and Strengthen Criminal Justice Systems in Line with 
International Human Rights Standards (2016-2021).31 
 
Contribution to the following thematic programme(s): 
1. The project relates to UNODC Thematic Programme on health and livelihood (Drug and 
HIV). In particular, the project relates to “expected accomplishment (a)”: “Increased 
implementation at the national level of evidence-based services related to drug use in the 
community.” 
 
Linkage to UNODC strategic framework, UNDAFs and to Sustainable 
Development Goals 
The project contributes to the following Sustainable Development Goals, Targets and Performance 
Indicators:  
 
Relevant UN Sustainable Development Goals32 Target(s) Indicator(s)33 
3 – Good Health and Well-Being 3.5 3.5.1 
 
The project contributes to the UN Sustainable Development Goals (SDGs) 3, focusing on ensuring 
healthy lives and promote well-being for all at all ages. The project is also fully aligned with the 
National Policy Agenda (2017-2022) and relevant sector and cross-sector strategies of the Palestinian 
Government, including the health sector strategy, national cross-sectoral gender strategies, and 
national juvenile justice strategy.    
The project contributes to key priorities of the United Nations Development Assistance Framework 
(UNDAF) for Palestine, which has been renewed in 2018.34 The UN’s agreed goal is to “enhance 
development prospects for the people of Palestine, by advancing Palestinian statehood, transparent 
and effective institutions, and addressing key drivers of vulnerability.” Therefore, the UNDAF for 
2018-2022 has been framed around four fundamental strategic priorities which readjust those define 
for 2014-2017 and is underpinned by the 2030 Agenda premise of “Leave No One Behind.” The 
project contributes to the UNDAF Strategic Priority Area 4, which stands that “All Palestinians, 
especially the most vulnerable who are often left behind, have access to quality services, including 
health and education and social protection systems, such as social insurance.” Under this Strategic 
Priority, UNODC has been supporting the Palestinian government in improving quality of drug 
________ 
31 Available online: https://www.unodc.org/documents/middleeastandnorthafrica//Regional-Programme-
doc/Regional_Programme_for_the_Arab_States_2016-2021.pdf  
32 All SDGs and targets can be found here: http://www.un.org/sustainabledevelopment/sustainable-
development-goals/  
33 All SDG indicators can be found here: 
https://unstats.un.org/sdgs/indicators/Global%20Indicator%20Framework_A. 
RES.71.313%20Annex.pdf      
34 http://www.ps.undp.org/content/dam/papp/docs/Publications/UNDP-papp-research-undaf_2018-
2022.pdf  
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treatment provided and national policy framework as a key vector for improving health care services 
and addressing the needs of vulnerable groups.  
 
I. DISBURSEMENT HISTORY 
Time periods 
throughout the 
life time of the 
project 
(01/2014 –
12/2018) (add the 
number of rows 
needed) 
Total Approved 
Budget                 
Expenditure   Expenditure in %      
January 2014 – 
December 2018 
 
USD 622,913  USD 530,364 85.1% 
 
Time period that 
will be covered 
by the evaluation 
Total Approved 
Budget                 
Expenditure   Expenditure in %      
January 2014 – 
October 2018  
USD 622,913.00 USD 590,000 94.7% 
 
II. PURPOSE OF THE EVALUATION  
According to UNODC Evaluation Policy, all projects and programmes in UNODC are to be 
evaluated at least every 4 years or 6 months before the project or programme finalizes. This final 
Independent Project Evaluation of the project “Supporting the Establishment-based Drug 
Dependence Treatment and Rehabilitation System for the Palestine National Rehabilitation Centre” 
(PSEY13) is the first and only evaluation of the project.  
 
The purpose of the final evaluation is three-folded, assessing; (1) the extent to which the objective, 
outputs and outcomes were met, (2) the utilization of resources in a wisely manner, (3) areas of 
improvement in term of project management but also in term of needs for further technical 
assistance.   
 
(1) This evaluation will assess the implementation of the project activities, the results obtained. 
It will enable UNODC to provide the donor and national counterparts with a report 
assessing the extent to which the objective, outputs and outcomes were met.  
(2) In addition, this evaluation will ensure accountability to the donor (KOICA), the national 
stakeholders and counterparts (Ministry of Health, Palestinian National Institute of Public 
Health). It will also assess whether the resources have been wisely utilized. 
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(3) This evaluation will also allow UNODC to identify areas of improvement not only in terms 
of project management but also in terms of continuation of technical assistance to the 
national counterpart. It will identify best practices, lessons learnt and needs of further 
assistance for potential future project with the Palestinian Government as well as for 
organizational learning and decision-making purposes.  
 
Furthermore, the following DAC criteria will be assessed during the evaluation: relevance, efficiency, 
effectiveness, impact and sustainability. In addition, established partnerships and cooperation as well 
as aspects of human rights and gender mainstreaming will be assessed. The evaluation will specifically 
assess how gender aspects have been mainstreamed into the project. Furthermore, lessons learned 
and best practices will be identified and recommendations based on the findings formulated.  
 
The main users of this evaluation are UNODC Programme Office in the State of Palestine as well as 
UNODC Regional Office for Middle East and North Africa (ROMENA). The Palestinian Ministry 
of Health will also benefit from the results of this evaluation, as well as the Palestine National 
Rehabilitation Centre (PNRC).  
 
III. SCOPE OF THE EVALUATION  
Unit of analysis (full project/programme/ parts 
of the project/programme; etc.) 
Full project PSE/Y13 
Time period of the project/programme 
covered by the evaluation 
January 2014 – September 2018 (end of field 
mission) 
Geographical coverage of the evaluation 
Palestinian Territories, West Bank (mainly 
Ramallah, Bethlehem) 
 
IV. KEY EVALUATION QUESTIONS  
Evaluation Criteria 
The evaluation will be conducted based on the following DAC criteria: relevance, efficiency, 
effectiveness, impact and sustainability, as well as design, partnerships and cooperation, human 
rights, gender equality and leaving no one behind as well as lesson learned and best practices. The 
questions will be further refined by the evaluator. 
Design 
The Design of a project or programme measures the extent to which the logical framework approach was adopted.  
1. Was the design of the project accurate and realistic in relation to its set objective and 
outcomes or should there be any change for any future similar project?  
2. Was the project designed in line with the national needs?  
Relevance 
Relevance is the extent to which the activity is suited to the priorities and policies of the target group, recipient and 
donor. 
3. To what extent were the implemented activities and services set up relevant and suitable to 
achieve the expected results?35  
________ 
35 The expected results can be divided into three categories: (i) the outputs, (ii) the outcomes, (iii) the intermediate and 
ultimate outcomes previously defined. (i) the outputs are the results which are achieved immediately after 
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4. To what extent were the implemented activities suited to the priorities and policies of the 
health sector actors and civil society?  
Efficiency 
Efficiency measures the outputs - qualitative and quantitative - in relation to the inputs. 
5. Has UNODC used its resources in an effective manner to achieve the objective and 
various outcomes? 
6. To what extent was the project’s governance structure adequate? 
Effectiveness 
Effectiveness is a measure of the extent to which an aid activity attains its objectives. 
7. To what extent did the project achieve its planned results (objective and outcomes) and 
which unachieved results should be targeted in future projects?  
8. To what extent did the strategy produce unintended outcomes (positive or negative)? 
Impact 
Impact is the positive and negative changes produced by a development intervention, directly or indirectly, intended or 
unintended. 
9. To what extent did the project contribute, or is likely to contribute to long-term impact 
and /or outcomes?  
10. To what extent did the project/ contribute to achieving the related Sustainable 
Development Goals? 
Sustainability 
Sustainability is concerned with measuring whether the benefits of an activity are likely to continue after donor 
funding has been withdrawn. 
11. To what extent are the project results generated through its activities likely to continue in 
Palestine after the project completion?  
12. To what extent has UNODC assistance helped to generate commitment of the health 
sector actors in the provision of a comprehensive rehabilitation treatment to continue even 
after completion of the project?  
Partnerships and cooperation 
The evaluation assesses the partnerships and cooperation established during the project/ programme as well as their 
functioning and value. 
13. To what extent were the UNODC partnerships in Palestine efficient and effective with 
regard to the implementation of the project?  
14. To which extent did UNODC take advantage and maximized its impact while working 
with partners and other stakeholders (mainly working with WHO and the National 
Institute for Public Health)?  
 Human rights, gender equality, and leaving no one behind  
The evaluation needs to assess the mainstreaming throughout the project/programme of human rights, gender 
equality, and the dignity of individuals, i.e. vulnerable groups. 
 
Human Rights 
15. To what extent were human rights considerations included in the project design and 
implementation?  
16. To what extent human rights principles have been taken into account by the PNRC staff 
to deal with drug users?  
Gender Equality 
                                                                                                                                                              
implementing an activity. (ii) the outcomes can be considered as mid-term results. (iii) the intermediate and ultimate 
outcomes are more long-term results and might be harder to assess at some extent.  
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17. To what extent was the project relevant to the needs and priorities as defined by 
beneficiaries, women and girls?  
18. To what extent has the project answered the service needs of vulnerable targeted groups? 
Leaving no one behind (optional) 
19. To what extent were under-represented and vulnerable groups among drug users included 
in the project design and implementation? 
Lessons learned and best practices36 
Lessons learned concern the learning experiences and insights that were gained throughout the project/ programme. 
20. Which were the lessons and recommendations that the UNODC Project Team should use 
and follow up upon for a possible new project focusing on the provision of aftercare?  
V. EVALUATION METHODOLOGY  
The methods used to collect and analyse data  
This evaluation will use methodologies and techniques as determined by the specific needs for 
information, the questions set out in the TOR and the availability of stakeholders and direct 
beneficiaries. In all cases, the evaluator is expected to analyse all relevant information sources, such as 
reports, programme documents, thematic programmes, internal review reports, programme files, 
evaluation reports (if available), financial reports and any other documents that may provide further 
evidence for triangulation, on which their conclusions will be based. The evaluator is also expected to 
use interviews, surveys or any other relevant quantitative and/or qualitative tools as a means to 
collect relevant data for the evaluation. Interviews should be made not only with senior management 
but also, and especially, other stakeholders such as specialised practitioners, social workers, 
psychologists, operational staff from the PNRC and direct beneficiaries (e.g.: drug users). The 
geographical frame will be mainly focusing on districts such as Ramallah and Bethlehem. While 
maintaining independence, the evaluation will be carried out based on a participatory approach, 
which seeks the views and assessments of all parties identified as the key stakeholders of the project/ 
programme, the Core Learning Partners (CLP).  
 
The present ToR provide basic information as regards to the methodology, which should not be 
understood as exhaustive. It is rather meant to guide the evaluator in elaborating an effective, 
efficient, and appropriate evaluation methodology that should be proposed, explained and justified in 
the Inception Report.  
 
In addition, the evaluator will be asked to present a summarized methodology (including an 
evaluation matrix) in the Inception Report outlining the evaluation criteria, indicators, sources of 
information and methods of data collection. This will include a detailed and concrete sampling 
strategy for all proposed samples (site visits, key informants, etc). The evaluation methodology must 
conform to the United Nations Evaluation Group (UNEG) Norms and Standards as well as the 
UNODC Evaluation Policy, Norms and Standards. 
 
While the evaluator shall fine-tune the methodology for the evaluation in an Inception Report, a 
mixed-methods approach of qualitative and quantitative methods is mandatory due to its 
appropriateness to ensure a gender-sensitive, inclusive methodology. Special attention shall be paid to 
an unbiased and objective approach and the triangulation of sources, methods, data, and theories. 
________ 
36 Good practices and lessons learned will be elaborated by the evaluator based on findings and conclusions drawn 
based on the analysis of the information gathered throughout the evaluation process. 
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Indeed, information stemming from secondary sources will be cross-checked and triangulated 
through data retrieved from primary research methods. Primary data collection methods need to be 
gender-sensitive as well as inclusive. 
 
The credibility of the data collection and analysis are key to the evaluation. Rival theories and 
competing explanations must be tested once plausible patterns emerge from triangulating data.  
 
The limitations to the evaluation need to be identified and discussed by the evaluator in the Inception 
Report, e.g. data constraints (such as missing baseline and monitoring data). Potential limitations as 
well as the chosen mitigating measures should be discussed. 
 
When designing the evaluation data collection tools and instruments, the evaluator needs to consider 
the analysis of certain relevant or innovative topics in the form of short case studies, analyses, etc. 
that would benefit the evaluation results.  
 
The main elements of the evaluation process are the following:   
• Preliminary desk review of all relevant project documentation, (Annex II of the evaluation 
ToR), as provided by the Project Manager and as further requested by the evaluation team, 
as well as relevant external documents (e.g. UNDAFs; SDGs; UN and global/regional 
strategies; etc.);  
• Preparation and submission of an Inception Report (containing preliminary findings of the 
desk review, refined evaluation questions, data collection instruments, sampling strategy, 
limitations to the evaluation, and timetable) to IEU for review and clearance before any field 
mission may take place; 
• Initial meetings and interviews with the Project Manager and other UNODC staff as well as 
stakeholders during the field mission;  
• Interviews (face-to-face and by telephone/skype), with key project stakeholders and 
beneficiaries, both individually and (as appropriate) in small groups/focus groups, as well as 
using surveys, questionnaires or any other relevant quantitative and/or qualitative tools as a 
means to collect relevant data for the evaluation;  
• Analysis of all available information;  
• Preparation of the draft evaluation report (based on Guidelines for Evaluation Report and 
Template Report to be found on the IEU website 
http://www.unodc.org/unodc/en/evaluation/index.html). The lead evaluator submits the 
draft report to the Project Manager for the review of factual errors (copying IEU) and the 
Project Manager shares with IEU for review, comments and clearance. Subsequently the 
Project Manager shares the final draft report with all CLPs for comments.  
• Preparation of the final evaluation report and an Evaluation Brief (2-pager). The evaluation 
team incorporates the necessary and requested changes and finalizes the evaluation report in 
accordance with the feedback received from IEU, the Project Manager and CLPs. It further 
includes a PowerPoint presentation on final evaluation findings and recommendations; 
• Presentation of final evaluation report and Evaluation Brief (2-pager) with its findings and 
recommendations to the target audience, stakeholders etc. (in person or if necessary through 
Skype). 
• In conducting the evaluation, the UNODC and the UNEG Evaluation Norms and 
Standards are to be taken into account. All tools, norms and templates to be mandatorily 
used in the evaluation process can be found on the IEU website: 
http://www.unodc.org/unodc/en/evaluation/index.html. 
 
The sources of data 
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The evaluation will utilize a mixture of primary and secondary sources of data. The primary sources 
include, among others, interviews with key stakeholders (face-to-face or by telephone), the use of 
surveys and questionnaires, field missions for case studies, focus group interviews, observation and 
other participatory techniques. Secondary data sources will include project documents and their 
revisions, progress and monitoring reports, external reports and strategies (e.g. UNDAFs; SDGs; 
country/regional/global strategies; etc.) and all other relevant documents, including visual 
information (e.g. eLearning, pictures, videos, etc.).  
 
Desk Review  
The evaluator will perform a desk review of all existing documentation (please see the preliminary list 
of documents to be consulted in Annex II of the evaluation ToR). This list is however not to be 
regarded as exhaustive as additional documentation may be requested by the evaluator. The evaluator 
needs to ensure that sufficient external documentation is used for the desk review.  
 
Phone interviews / face-to-face consultations 
The evaluator will conduct phone interviews / face-to-face consultations with, but not limited to the 
identified individuals from the following groups of stakeholders: 
• Palestinian Ministry of Health and National Institute for Public Health; 
• Relevant international and regional organizations (e.g.: WHO, UNRWA); 
• Non-governmental organizations working with UNODC (Caritas and al-Maqdese);  
• UNODC management and staff at HQ and in the field; 
• Health sector actors (e.g.: medicine practitioners, psychologists, social workers, operational 
staff at the PNRC); 
• Relevant medical staff  from hospitals and methadone centre in Bethlehem (Only 
three staff  from the methadone centres and the hospital administration currently 
included in Annex III. Names of  additional staff  to be interviewed during the 
field mission will be provided to the evaluator at the inception phase);  
• Palestinian Civil Police officers (e.g.: anti-narcotics department); 
•  Selected staff trained to operate a centre for drug users (The staff will be selected and 
trained by July. The names of such staff to be interviewed during the field mission will be 
provided to the evaluator at the inception phase);  
• To the extent possible, vulnerable groups, such as drug users having received assistance at 
the drug dependence treatment and rehabilitation services; 
• Others as requested. 
 
 
 
Questionnaire 
A questionnaire (on-line) is to be developed and used to help collect the views of trainees and 
management staff from the PNRC, if deemed appropriate. 
 
VI. TIMEFRAME AND DELIVERABLES  
Duties Time frame Location Deliverables 
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Desk review and drafting 
of Inception Report  
30/07/2018– 
14/08/2018 (12 
working days for 
the evaluator) 
Home base Draft Inception report in line 
with UNODC evaluation 
norms and standards37  
Review of draft Inception 
Report by IEU  
15/08/2018– 
21/08/2018 
(1 week for IEU 
review) 
 Comments on the draft 
Inception Report to the 
evaluation team 
Incorporation of 
comments from IEU (can 
entail various rounds of 
comments from IEU) 
22/08/2018– 
31/08/2018 (3 
w/d for the 
evaluator) 
(1 week for IEU 
review) 
Home base Revised draft Inception 
Report 
Deliverable A:  Final 
Inception Report in line 
with UNODC evaluation 
norms, standards, 
guidelines and templates 
By 31/08/2018 
(overall 15 w/d 
for the 
evaluator) 
 
 Final Inception report to be 
cleared by IEU at least one 
week before the field 
mission can get started 
Evaluation mission: 
briefing, interviews with 
staff at UNODC HQ/FO 
(including by 
phone/skype); observation; 
focus groups; presentation 
of preliminary observations 
(if applicable) 
15/09/208 – 
22/09/2018 (8 
w/d for the 
evaluator) 
UNODC 
Country 
Office; 
Palestinian 
Territories, 
West Bank 
(mainly 
Ramallah, 
Bethlehem) 
Interviews and data collection 
Drafting of the evaluation 
report; submission to 
Project Management and 
IEU;  
27/09/2018– 
17/10/2018 (15 
w/d for the 
evaluator) 
Home base Draft evaluation report  
Review of IEU for quality 
assurance and Project 
Management for factual 
errors 
18/10/2018– 
01/11/2018 
(2 weeks for review) 
 Comments on the draft 
evaluation report to the 
evaluation team 
________ 
37 https://www.unodc.org/unodc/en/evaluation/normative-tools.html#Inception_Report  
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Consideration of 
comments from the project 
manager and incorporation 
of comments from IEU 
(can entail various rounds 
of comments from IEU) 
02/11/2018 – 
19/11/2018 (6 
w/d for the 
evaluator + 1 
week for IEU 
review) 
Home base Revised draft evaluation 
report  
Deliverable B:  Draft 
Evaluation Report in line 
with UNODC evaluation 
norms, standards, 
guidelines and templates 
By 19/11/2018 
(overall 29 w/d 
for the 
evaluator) 
9-13 weeks 
 Draft evaluation report, to 
be cleared by IEU 
IEU to share draft 
evaluation report with Core 
Learning Partners for 
comments 
20/11/2018 – 
30/11/2018 
(2 weeks) 
 Comments of CLPs on the 
draft report 
Consideration of 
comments from Core 
Learning Partners and 
preparation of draft 
Evaluation Brief  
03/12/2018 – 
05/12/2018 (3 
w/d for the 
evaluator) 
Home base Revised draft evaluation 
report 
Final review by IEU; 
incorporation of comments 
and finalization of report 
and Evaluation Brief (can 
entail various rounds of 
comments from IEU) 
06/12/2018 –
17/12/2018 (3 
w/d for the 
evaluator + 1 
week for IEU 
review) 
Home base Revised draft evaluation 
report; draft Evaluation Brief 
Presentation of evaluation 
results (to be reviewed and 
cleared by IEU) 
18/12/2018 (1 
w/d for the 
evaluator) 
 Presentation of evaluation 
results 
Deliverable C:  Final 
evaluation report; 
presentation of 
evaluation results; 
Evaluation Brief (2-
pager)  
By 17/12/2018 
(7 overall w/d 
for the 
evaluator) 
 
 Final evaluation report; 
Evaluation Brief and 
presentation of evaluation 
results, both to be cleared 
by IEU 
Project Management: 
Finalise Evaluation Follow-
up Plan in ProFi  
By 06/01/2019  
 
 Final Evaluation Follow-up 
Plan to be cleared by IEU 
Project Management: 
Disseminate final 
evaluation report 
By 07/01/2019  Final evaluation report 
disseminated to internal and 
external stakeholders 
ANNEXES 
 
 
 
 
43 
IEU: facilitate the external 
Evaluation Quality 
Assessment of the Final 
Report 
January 2019   
 
The UNODC Independent Evaluation Unit may change the evaluation process, timeline, approach, etc. as necessary 
at any point throughout the evaluation-process. 
 
VII. EVALUATION TEAM COMPOSITION  
The evaluator will report exclusively to the Chief or Deputy Chief of the UNODC Independent 
Evaluation Unit. 
 
Role Number of consultants/ evaluators 
(national/international) 
Specific expertise required38 
Evaluator 1 independent International consultant Evaluation methodology; evaluation in 
the UN system, preferably previous 
experience in health sector and/or drug 
treatment 
 
The independent external international evaluator will not act as representatives of any party and must 
remain independent and impartial. The qualifications and responsibilities for the evaluator are 
specified in the respective job descriptions attached to these Terms of Reference (Annex 1). The 
evaluator will report exclusively to the chief or deputy chief of the UNODC Independent Evaluation 
Unit, who are the exclusive clearing entity for all evaluation deliverables and products. 
Absence of Conflict of Interest 
According to UNODC rules, the evaluator must not have been involved in the design and/or 
implementation, supervision and coordination of and/or have benefited from the 
programme/project or theme under evaluation. 
 
Furthermore, the evaluator shall respect and follow the UNEG Ethical Guidelines for conducting 
evaluations in a sensitive and ethical manner. 
 
________ 
38 Please add the specific technical expertise needed (e.g. expertise in anti-corruption; counter terrorism; etc.) – 
please note that expertise in human rights and gender equality  is required.  
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VIII. MANAGEMENT OF THE EVALUATION 
PROCESS  
Roles and responsibilities of the Project Manager 
The Project Manager is responsible for: 
• managing the evaluation process, with the assistance of the Reporting and Project 
Development Officer, 
• drafting and finalizing the ToR, with the assistance of the Reporting and Project 
Development Officer, 
• selecting Core Learning Partners (representing a balance of men, women and other 
marginalised groups) and informing them of their role,  
• recruiting the evaluation team following clearance by IEU, ensuring issued contracts ahead 
of the start of the evaluation process in line with the cleared ToR. In case of any delay, IEU 
and the evaluation team are to be immediately notified, 
• providing desk review materials (including data and information on men, women and other 
marginalised groups) to the evaluation team including the full TOR,  
• liaising with the Core Learning Partners,  
• reviewing the draft report for factual errors only, with the assistant of the Reporting and 
Project Development Officer, 
• developing a follow-up plan for the usage of the evaluation results and recording of the 
implementation of the evaluation recommendations (to be updated once per year), with the 
assistant of the Reporting and Project Development Officer, 
• disseminate the final evaluation report and communicate evaluation results to relevant 
stakeholders as well as facilitate the presentation of evaluation results; 
• ensure that all payments related to the evaluation are fulfilled within 5 working days after 
IEU’s request - non-compliance by Project/Programme Management may results in the 
decision to discontinue the evaluation by IEU. 
 
The Project Manager, with the assistance of the Reporting and Project Development Officer, will be 
in charge of providing logistical support to the evaluation team including arranging the field 
missions of the evaluation team, including but not limited to:  
• All logistical arrangements for the travel (including travel details; DSA-payments; 
transportation; etc.) 
• All logistical arrangement for the meetings/interviews/focus groups/etc., ensuring interview 
partners adequately represent men, women and other marginalised groups (including 
independent translator/interpreter if needed); set-up of interview schedules; arrangement of 
ad-hoc meetings as requested by the evaluation team; transportation from/to the interview 
venues; scheduling sufficient time for the interviews (around 45 minutes); ensuring that 
members of the evaluation team and the respective interviewees are present during the 
interviews; etc.) 
• All logistical arrangements for the presentation of the evaluation results;  
• Ensure timely payment of all fees/DSA/etc. (payments for the evaluation team must be 
released within 5 working days after the respective deliverable is cleared by IEU).  
 
Roles and responsibilities of the evaluation stakeholders 
Members of the Core Learning Partnership (CLP) are identified by the project manager. The CLPs 
are the main stakeholders, i.e. a limited number of those deemed as particularly relevant to be 
involved throughout the evaluation process, i.e. in reviewing and commenting on the TOR and the 
ANNEXES 
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evaluation questions, reviewing and commenting on the draft evaluation report, as well as facilitating 
the dissemination and application of the results and other follow-up action. Stakeholders include all 
those to be invited to participate in the interviews and surveys, including the CLPs. As some of the 
CLPs do not read/write English, parts of the ToR as well as draft evaluation report will be translated 
to be shared and reviewed by the CLPs.  
Roles and responsibilities of the Independent Evaluation Unit 
The Independent Evaluation Unit (IEU) provides mandatory normative tools, guidelines and 
templates to be used in the evaluation process. Please find the respective tools on the IEU web site 
http://www.unodc.org/unodc/en/evaluation/evaluation.html. Furthermore, IEU provides 
guidance, quality assurance and evaluation expertise, as well as interacts with the project manager and 
the evaluation team throughout the evaluation process. IEU may change the evaluation process, 
timeline, approach, etc. as necessary at any point throughout the evaluation-process.  
IEU reviews, comments on and clears all steps and deliverables during the evaluation process: Terms 
of Reference; Selection of the evaluator, Inception Report; Draft Evaluation Report; Final Evaluation 
Report and an Evaluation Brief; Evaluation Follow-up Plan. IEU further publishes the final 
evaluation report and the Evaluation Brief on the UNODC website, as well as sends the final 
evaluation report to an external evaluation quality assurance provider. Moreover, IEU may decide, in 
consultation with Project Management, to upgrade any Independent Project Evaluation to an In-
Depth Evaluation considering e.g. an unforeseen higher involvement of IEU staff in the evaluation 
process.  
 
IX. PAYMENT MODALITIES  
The evaluator will be issued consultancy contracts and paid in accordance with UNODC rules and 
regulations. The contracts are legally binding documents in which the evaluation team agrees to 
complete the deliverables by the set deadlines. Payment is correlated to deliverables and three 
instalments are typically foreseen:  
 
1. The first payment upon clearance of the Inception Report (in line with UNODC 
evaluation norms, standards, guidelines and templates) by IEU; 
2. The second payment upon clearance of the Draft Evaluation Report (in line with 
UNODC norms, standards, evaluation guidelines and templates) by IEU; 
3. The third and final payment (i.e. the remainder of the fee) only after completion of 
the respective tasks, receipt of the final report, Evaluation Brief (in line with 
UNODC evaluation norms, standards, guidelines and templates) and clearance by 
IEU, as well as presentation of final evaluation findings and recommendations. 
75 percent of the daily subsistence allowance and terminals is paid in advance before travelling. The 
balance is paid after the travel has taken place, upon presentation of boarding passes and the 
completed travel claim forms. 
 
IEU is the sole entity to request payments to be released in relation to evaluation. 
Project/Programme Management must fulfil any such request within 5 working days to ensure the 
independence of this evaluation-process. Non-compliance by Project/Programme Management may 
result in the decision to discontinue the evaluation by IEU.
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ANNEX II. EVALUATION TOOLS: QUESTIONNAIRES 
AND INTERVIEW GUIDES  
FACE TO FACE/SKYPE INTERVIEW: ALL KEY 
STAKEHOLDERS 
Information Sheet 
You are invited to participate in an evaluation which seeks to learn more about your experiences of 
the Project PSEY13 which was implemented by UNODC. This project aimed to develop a 
comprehensive system of drug dependence treatment and rehabilitation that is science- and human 
rights-based in place and fully integrated into the Palestinian health system; and a comprehensive 
package of integrated and voluntary drug dependence treatment and rehabilitation services with a 
continuum of care through community-based services that are gender sensitive, science- and human 
rights-based is made available at the PNRC. I am interested to hear your views on this project in 
terms of its achieving these outcomes.  
 
I (Name of Evaluator) am the evaluator and I am interviewing people for this evaluation. I am not 
collecting names or other personal identifiers – people’s identities will remain anonymous. Your 
participation in this evaluation is voluntary. You can withdraw at any time.   
Consent 
Please complete this form after you have read the Information Sheet and/or listened to an 
explanation about the evaluation. Thank you for considering taking part in this evaluation. 
I understand that if I decide at any time that I no longer wish to participate in this evaluation, I can 
notify the evaluator and withdraw from it immediately without giving any reason.  
 
I understand that confidentiality and anonymity will be maintained and my identity will 
not feature in the evaluation report. 
Participant’s Statement: 
I agree that the evaluation named above has been explained to me to my satisfaction and I agree to 
take part in the evaluation. I have read the Information Sheet about the evaluation, and understand 
what the evaluation involves. 
Signed      Date 
Expert Evaluator Statement: 
Confirm that I have carefully explained the nature, demands and any foreseeable risks (where 
applicable) of the proposed evaluation to the participant. 
 
Signed       Date 
 
Yes No 
  Yes No 
  
Please tick 
or initial 
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INTERVIEW GUIDE 
How was the design of PSEY13 accurate and realistic in relation to its set objective and 
outcomes  
Probe should there be any change for any future similar project?  
How was PSEY13 designed in line with the national needs? 
Probe 2017 situation assessment report. 
How were the implemented activities and services set up by PSEY13 relevant and suitable to 
achieve the expected results?  
How were the implemented activities of PSEY13 suited to the priorities and policies of the 
health sector actors and civil society? 
Probe SOPs, OST treatment guidelines, PNRC mission statement etc 
How has UNODC used its resources in an effective manner to achieve the objective and 
various outcomes of PSEY13? 
How has PSEY13 ensured its governance structure is adequate? 
Probe M& E, cost analysis for running of the PNRC 
How has PSEY13 supported the development of a comprehensive system of drug dependence 
treatment which is carefully established and integrated into the health system? 
How has PSEY13 strengthened institutional and human resource capacity to provide evidence 
based opioid substitution therapy and drug dependence treatment services at the PNRC? 
Probe which unachieved results should be targeted in future projects?  
Did PSEY13 produce unintended outcomes (positive or negative)? 
How has PSEY13 contributed, or is likely to contribute to long-term impact and /or 
outcomes? 
Probe  alignment with SDG goals, UNODC programming, UNDAF, training cohorts 
How are the generated results of PSEY13 through its activities likely to continue in Palestine 
after the project completion?  
How has UNODC assistance helped to generate commitment of the health sector actors in the 
provision of a comprehensive rehabilitation treatment to continue even after completion of 
the project? 
Probe sustainability of training cascade, donor support, resource allocation 
Were the UNODC partnerships in Palestine efficient and effective with regard to the 
implementation of PSEY13?  
Probe NGOs, CSOs, key stakeholders 
How were human rights considerations included in the PSEY13 project design and 
implementation?  
How was PSEY13 relevant to the needs and priorities as defined by beneficiaries, women and 
girls? 
Probe Are gender responsive services appropriate or were any aspects were overlooked or 
omitted. 
How does PSEY13 answer the service needs of vulnerable targeted groups? 
Probe loss to follow up, new trends in key groups 
Are there any key vulnerable groups of drug users identified which may not access the 
PNRC? 
What are the lessons and recommendations that the UNODC Project Team should use and 
follow up upon for a possible new project focusing on the provision of aftercare? 
How can a new follow on project linked to the PNRC strengthen the gains made by PSEY13? 
 
Thank you for your participation in this evaluation. 
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FOCUS GROUP GUIDE: ALL KEY STAKEHOLDERS 
 
Information Sheet 
You are invited to participate in an evaluation which seeks to learn more about your experiences of 
the Project PSEY13 which was implemented by UNODC. This project aimed to develop a 
comprehensive system of drug dependence treatment and rehabilitation that is science- and human 
rights-based in place and fully integrated into the Palestinian health system; and a comprehensive 
package of integrated and voluntary drug dependence treatment and rehabilitation services with a 
continuum of care through community-based services that are gender sensitive, science- and human 
rights-based is made available at the PNRC. I am interested to hear your views on this project in 
terms of its achieving these outcomes.  
 
I (Name of Evaluator) am the evaluator and I am interviewing people for this evaluation. I am not 
collecting names or other personal identifiers – people’s identities will remain anonymous. Your 
participation in this evaluation is voluntary. You can withdraw at any time.   
Consent 
Please complete this form after you have read the Information Sheet and/or listened to an 
explanation about the evaluation. Thank you for considering taking part in this evaluation. 
I understand that if I decide at any time that I no longer wish to participate in this evaluation, I can 
notify the evaluator and withdraw from it immediately without giving any reason.  
 
I understand that confidentiality and anonymity will be maintained and my identity will 
not feature in the evaluation report. 
 
 
Participant’s Statement: 
I agree that the evaluation named above has been explained to me to my satisfaction and I agree to 
take part in the evaluation. I have read the Information Sheet about the evaluation, and understand 
what the evaluation involves. 
Signed      Date 
 
 
Expert Evaluator Statement: 
Confirm that I have carefully explained the nature, demands and any foreseeable risks (where 
applicable) of the proposed evaluation to the participant. 
 
Signed       Date 
 
Yes No 
  Yes No 
  
Please tick 
or initial 
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FOCUS GROUP DISCUSSION GUIDE 
 
How was the design of PSEY13 accurate and realistic in relation to its set objective and 
outcomes  
Probe should there be any change for any future similar project?  
How was PSEY13 designed in line with the national needs? 
Probe 2017 situation assessment report. 
How were the implemented activities and services set up by PSEY13 relevant and suitable to 
achieve the expected results?  
How were the implemented activities of PSEY13 suited to the priorities and policies of the 
health sector actors and civil society? 
Probe SOPs, OST treatment guidelines, PNRC mission statement etc 
How has UNODC used its resources in an effective manner to achieve the objective and 
various outcomes of PSEY13? 
How has PSEY13 ensured its governance structure is adequate? 
Probe M& E, cost analysis for running of the PNRC 
How has PSEY13 supported the development of a comprehensive system of drug dependence 
treatment which is carefully established and integrated into the health system? 
How has PSEY13 strengthened institutional and human resource capacity to provide evidence 
based opioid substitution therapy and drug dependence treatment services at the PNRC? 
Probe which unachieved results should be targeted in future projects?  
Did PSEY13 produce unintended outcomes (positive or negative)? 
How has PSEY13 contributed, or is likely to contribute to long-term impact and /or 
outcomes? 
Probe  alignment with SDG goals, UNODC programming, UNDAF, training cohorts 
How are the generated results of PSEY13 through its activities likely to continue in Palestine 
after the project completion?  
How has UNODC assistance helped to generate commitment of the health sector actors in the 
provision of a comprehensive rehabilitation treatment to continue even after completion of 
the project? 
Probe sustainability of training cascade, donor support, resource allocation 
Were the UNODC partnerships in Palestine efficient and effective with regard to the 
implementation of PSEY13?  
Probe NGOs, CSOs, key stakeholders 
How were human rights considerations included in the PSEY13 project design and 
implementation?  
How was PSEY13 relevant to the needs and priorities as defined by beneficiaries, women and 
girls? 
Probe Are gender responsive services appropriate or were any aspects were overlooked or 
omitted. 
How does PSEY13 answer the service needs of vulnerable targeted groups? 
Probe loss to follow up, new trends in key groups 
Are there any key vulnerable groups of drug users identified which may not access the 
PNRC? 
What are the lessons and recommendations that the UNODC Project Team should use and 
follow up upon for a possible new project focusing on the provision of aftercare? 
How can a new follow on project linked to the PNRC strengthen the gains made by PSEY13? 
 
Thank you for your participation in this evaluation. 
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ANNEX III. DESK REVIEW LIST  
Documents reviewed 
Document – name Reviewe
d (y/n) 
Comment
s 
UNODC documents 
Terms of Reference Final Independent Project Evaluation “Supporting the 
establishment of evidence-based drug dependence treatment and 
rehabilitation system for the Palestine National Rehabilitation Centre” 
PSEY13, June 2018 
Y Very useful 
PSEY13 - Palestinian National Rehabilitation Centre Evidence based drug 
dependence treatment and rehabilitation system. Training Report, July 2018 
Y Very useful 
Final report UNODC Contract 5131 Supporting the establishment of an 
evidence-based drug dependence treatment and rehabilitation system for 
the Palestine National Rehabilitation Center "Brief interventions in 
substance abuse problems" PRCS building, Ramallah, West Bank, OPT 
17.08 to 21.08.2014. 
Y  
Financial Reports 31st December 2013 Y  
Financial Reports 31st December 2014 Y  
Financial Reports 31st December 2015 Y  
Financial Reports 31st December 2016 Y  
Financial Reports 31st December 2017 Y  
Press Release.  UNODC and KOICA sign Memorandum of Understanding 
to support the establishment of an evidence-based drug dependence 
treatment system for the Palestinian National Rehabilitation Center.. 
December 2013 
Y  
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Progress Report Annual Progress Report (S/APR). Period covered by the 
report: 1Jan. - 31Dec. 2104 
Y  
Annual Progress Report for Project PSEY13 1st January – 31 December 
2015 
Y  
Annual Progress Report for Project PSEY13 1st January – 31 December 
2016 
Y  
Annual Progress Report for Project PSEY13 1st January – 31 December 
2017 
Y  
Annual Progress Report for Project PSEY13 1st January – 30th June 2018 Y  
Project Document November 2013 Y  
Project Revision Document 2016 Y  
Project Revision Document 2017 Y  
Project Revision Document 2018 Y  
External documents 
Estimating the Extent of Illicit Drug Use in Palestine Palestinian National 
Institute of Public Health, Ministry of Health , UNODC/KOICA/WHO 
occupied Palestinian Territory, November 2017. 
Y Very useful 
Illicit Drug Use in Palestine: A Qualitative Investigation Formative phase 
study report. Palestinian National Institute of Public Health, Ministry of 
Health, UNODC/KOICA/WHO occupied Palestinian Territory, 
November 2017.  
Y Very useful 
Palestinian Central Bureau of Statistics. (December 2011). Palestinians at the end 
of 2011. 
http://www.pcbs.gov.ps/Portals/_pcbs/PressRelease/palestineEnd2011E.pdf  
Y  
Palestinian Central Bureau of Statistics, MDGs Indicators in Palestine, 
1994‐ 2008:  
http://www.pcbs.gov.ps/Portals/_pcbs/mdgs/52b82275-945e-4f76-b5b4-
Y Very useful 
 52 
 
e6eb0b25b543.pdf 
United Nations Development Assistance Framework State of Palestine 2018-
2022http://www.ps.undp.org/content/dam/papp/docs/Publications/UNDP-papp-
research-undaf_2018-2022.pdf;  
Y  
UNODC Regional Programme for the Arab States to Prevent and Combat 
Crime, Terrorism and Health Threats and Strengthen Criminal Justice 
Systems in Line with International Human Rights Standards (2016-2021) 
Y  
UNODC website and brochure: UNODC and the Sustainable 
Development Goals 
https://www.unodc.org/unodc/en/about-unodc/sustainable-development-goals/sdgs-
index.html 
https://www.unodc.org/documents/SDGs/UNODC-SDG_brochure_LORES.pdf 
Y  
ECOSOC Report of the Inter-agency and Expert Group on Sustainable 
Development Goal Indicators (E/CN.3/2017/2*) 
Y  
UNODC Independent Evaluation Unit: Meta-Analysis 2015-2016 
http://www.unodc.org/documents/evaluation/Meta-
Analysis/UNODC_IEU_Evaluation_Meta-Analysis_2015-2016.pdf 
Y  
UNODC Independent Evaluation Unit: Evaluation-based analysis of good 
practices in UNODC's approach to capacity building 
http://www.unodc.org/documents/evaluation/Knowledge-
Products/UNODC_IEU_Evaluation-
based_Capacity_Building_Analysis_final_October_2017.pdf 
Y  
UNODC Position Paper on Human Rights (2011) 
http://www.unodc.org/documents/justice-and-prison-
reform/UNODC_Human_rights_position_paper_2012.pdf  
Y  
Guidance Note on Gender Mainstreaming in UNODC (2013) 
http://www.un.org/womenwatch/directory/docs/UNODC-GuidanceNote-
GenderMainstreaming.pdf  
Y  
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UNODC/UNOV Strategy for Gender Equality and the Empower ment of 
Women (2018-2021) 
https://www.unodc.org/documents/Gender/UNOV-
UNODC_Strategy_for_Gender_Equality_and_the_Empowerment_of_Women_20
18-2021_FINAL.pdf 
Y  
UNODC evaluation guidelines, templates, handbook, policy 
http://www.unodc.org/unodc/en/evaluation/normative-tools.html 
Y  
UNODC Inception Report Guidelines and Template 
https://www.unodc.org/unodc/en/evaluation/normative-tools.html#Inception_Report   
Y  
UNODC Evaluation Report Guidelines and Template 
https://www.unodc.org/unodc/en/evaluation/normative-tools.html#Eval_Report 
Y  
UNODC Evaluation Quality Assessment 
http://www.unodc.org/unodc/en/evaluation/Evaluation-based-knowledge-
products.html#EQAs 
Y  
UNEG: Integrating human rights and gender equality in evaluation 
http://www.uneval.rgdetail/980  
Y  
UNEG Norms and Standards for Evaluation (2016) 
www.unevaluation.org/document/download/2601  
Y  
UNEG Ethical Guidelines for Evaluation 
www.uneval.org/document/download/548  
Y  
United Nations Development Assistance Framework Guidance (2017) 
https://undg.org/document/2017-undaf-guidance/ 
Y  
International Standards for the Treatment of Drug Use Disorders 2017 
UNODC/WHO (Draft for field testing) 
Y Very useful 
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TREATNET Quality Standards for Drug Dependence Treatment and Care 
Services 2012 
Y Very useful 
 
Number of external documents reviewed: 23 
Overall number of documents reviewed: 41 
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ANNEX IV. LIST OF PERSONS CONTACED DURING 
THE EVALUATION  
Number of 
interviewees 
Organisation Type of stakeholder Sex disaggregated 
data 
Country 
7 UNODC Project development, 
management and 
coordination  
Male: 4 
Female: 3 
Austria, Egypt, 
Palestine 
1 UN Country 
Team 
UNSCO Female: 1 Jerusalem 
2 KOICA Donor Male:  1 
Female: 1 
Ramallah, Palestine 
7 Palestinian 
Ministry of Health 
Methadone 
Centre;  
WHO; 
Palestinian Civil 
Police, Anti 
Narcotic 
Department 
National 
Programme on 
Drug Control, 
criminal justice 
and crime 
prevention 
National Counterpart Male:  4 
Female: 3 
Ramallah, Palestine 
3 Caritas 
Al Maqdese 
Al Sadiq al 
Tayyeb 
NGO Male:  3 
 
Jerusalem 
3 Consultants Beneficiary Male:  2 
Female: 1 
United Kingdom, 
Switzerland and 
Spain 
7 Staff at the 
PNRC 
Beneficiary Male:  2 
Female: 5 
Bethlehem, 
Palestine  
Total: 30   Male: 16 
Female: 14 
 
 
